Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
ABSTRACT Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for PSP, have excellent specificity, but their sensitivity is limited for variant PSP syndromes with presen...
Uložené v:
| Vydané v: | Movement disorders Ročník 32; číslo 6; s. 853 - 864 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
Wiley
01.06.2017
|
| Predmet: | |
| ISSN: | 0885-3185, 1531-8257, 1531-8257 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | ABSTRACT
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for PSP, have excellent specificity, but their sensitivity is limited for variant PSP syndromes with presentations other than Richardson's syndrome.
Objective: We aimed to provide an evidence‐ and consensus‐based revision of the clinical diagnostic criteria for PSP.
Methods: We searched the PubMed, Cochrane, Medline, and PSYCInfo databases for articles published in English since 1996, using postmortem diagnosis or highly specific clinical criteria as the diagnostic standard. Second, we generated retrospective standardized clinical data from patients with autopsy‐confirmed PSP and control diseases. On this basis, diagnostic criteria were drafted, optimized in two modified Delphi evaluations, submitted to structured discussions with consensus procedures during a 2‐day meeting, and refined in three further Delphi rounds.
Results: Defined clinical, imaging, laboratory, and genetic findings serve as mandatory basic features, mandatory exclusion criteria, or context‐dependent exclusion criteria. We identified four functional domains (ocular motor dysfunction, postural instability, akinesia, and cognitive dysfunction) as clinical predictors of PSP. Within each of these domains, we propose three clinical features that contribute different levels of diagnostic certainty. Specific combinations of these features define the diagnostic criteria, stratified by three degrees of diagnostic certainty (probable PSP, possible PSP, and suggestive of PSP). Clinical clues and imaging findings represent supportive features.
Conclusions: Here, we present new criteria aimed to optimize early, sensitive, and specific clinical diagnosis of PSP on the basis of currently available evidence. © 2017 International Parkinson and Movement Disorder Society |
|---|---|
| AbstractList | ABSTRACT
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for PSP, have excellent specificity, but their sensitivity is limited for variant PSP syndromes with presentations other than Richardson's syndrome.
Objective: We aimed to provide an evidence‐ and consensus‐based revision of the clinical diagnostic criteria for PSP.
Methods: We searched the PubMed, Cochrane, Medline, and PSYCInfo databases for articles published in English since 1996, using postmortem diagnosis or highly specific clinical criteria as the diagnostic standard. Second, we generated retrospective standardized clinical data from patients with autopsy‐confirmed PSP and control diseases. On this basis, diagnostic criteria were drafted, optimized in two modified Delphi evaluations, submitted to structured discussions with consensus procedures during a 2‐day meeting, and refined in three further Delphi rounds.
Results: Defined clinical, imaging, laboratory, and genetic findings serve as mandatory basic features, mandatory exclusion criteria, or context‐dependent exclusion criteria. We identified four functional domains (ocular motor dysfunction, postural instability, akinesia, and cognitive dysfunction) as clinical predictors of PSP. Within each of these domains, we propose three clinical features that contribute different levels of diagnostic certainty. Specific combinations of these features define the diagnostic criteria, stratified by three degrees of diagnostic certainty (probable PSP, possible PSP, and suggestive of PSP). Clinical clues and imaging findings represent supportive features.
Conclusions: Here, we present new criteria aimed to optimize early, sensitive, and specific clinical diagnosis of PSP on the basis of currently available evidence. © 2017 International Parkinson and Movement Disorder Society PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for PSP, have excellent specificity, but their sensitivity is limited for variant PSP syndromes with presentations other than Richardson's syndrome.BACKGROUNDPSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for PSP, have excellent specificity, but their sensitivity is limited for variant PSP syndromes with presentations other than Richardson's syndrome.We aimed to provide an evidence- and consensus-based revision of the clinical diagnostic criteria for PSP.OBJECTIVEWe aimed to provide an evidence- and consensus-based revision of the clinical diagnostic criteria for PSP.We searched the PubMed, Cochrane, Medline, and PSYCInfo databases for articles published in English since 1996, using postmortem diagnosis or highly specific clinical criteria as the diagnostic standard. Second, we generated retrospective standardized clinical data from patients with autopsy-confirmed PSP and control diseases. On this basis, diagnostic criteria were drafted, optimized in two modified Delphi evaluations, submitted to structured discussions with consensus procedures during a 2-day meeting, and refined in three further Delphi rounds.METHODSWe searched the PubMed, Cochrane, Medline, and PSYCInfo databases for articles published in English since 1996, using postmortem diagnosis or highly specific clinical criteria as the diagnostic standard. Second, we generated retrospective standardized clinical data from patients with autopsy-confirmed PSP and control diseases. On this basis, diagnostic criteria were drafted, optimized in two modified Delphi evaluations, submitted to structured discussions with consensus procedures during a 2-day meeting, and refined in three further Delphi rounds.Defined clinical, imaging, laboratory, and genetic findings serve as mandatory basic features, mandatory exclusion criteria, or context-dependent exclusion criteria. We identified four functional domains (ocular motor dysfunction, postural instability, akinesia, and cognitive dysfunction) as clinical predictors of PSP. Within each of these domains, we propose three clinical features that contribute different levels of diagnostic certainty. Specific combinations of these features define the diagnostic criteria, stratified by three degrees of diagnostic certainty (probable PSP, possible PSP, and suggestive of PSP). Clinical clues and imaging findings represent supportive features.RESULTSDefined clinical, imaging, laboratory, and genetic findings serve as mandatory basic features, mandatory exclusion criteria, or context-dependent exclusion criteria. We identified four functional domains (ocular motor dysfunction, postural instability, akinesia, and cognitive dysfunction) as clinical predictors of PSP. Within each of these domains, we propose three clinical features that contribute different levels of diagnostic certainty. Specific combinations of these features define the diagnostic criteria, stratified by three degrees of diagnostic certainty (probable PSP, possible PSP, and suggestive of PSP). Clinical clues and imaging findings represent supportive features.Here, we present new criteria aimed to optimize early, sensitive, and specific clinical diagnosis of PSP on the basis of currently available evidence. © 2017 International Parkinson and Movement Disorder Society.CONCLUSIONSHere, we present new criteria aimed to optimize early, sensitive, and specific clinical diagnosis of PSP on the basis of currently available evidence. © 2017 International Parkinson and Movement Disorder Society. Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for PSP, have excellent specificity, but their sensitivity is limited for variant PSP syndromes with presentations other than Richardson's syndrome.Objective: We aimed to provide an evidence- and consensus-based revision of the clinical diagnostic criteria for PSP.Methods: We searched the PubMed, Cochrane, Medline, and PSYCInfo databases for articles published in English since 1996, using postmortem diagnosis or highly specific clinical criteria as the diagnostic standard. Second, we generated retrospective standardized clinical data from patients with autopsy-confirmed PSP and control diseases. On this basis, diagnostic criteria were drafted, optimized in two modified Delphi evaluations, submitted to structured discussions with consensus procedures during a 2-day meeting, and refined in three further Delphi rounds.Results: Defined clinical, imaging, laboratory, and genetic findings serve as mandatory basic features, mandatory exclusion criteria, or context-dependent exclusion criteria. We identified four functional domains (ocular motor dysfunction, postural instability, akinesia, and cognitive dysfunction) as clinical predictors of PSP. Within each of these domains, we propose three clinical features that contribute different levels of diagnostic certainty. Specific combinations of these features define the diagnostic criteria, stratified by three degrees of diagnostic certainty (probable PSP, possible PSP, and suggestive of PSP). Clinical clues and imaging findings represent supportive features.Conclusions: Here, we present new criteria aimed to optimize early, sensitive, and specific clinical diagnosis of PSP on the basis of currently available evidence. Background : PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for PSP, have excellent specificity, but their sensitivity is limited for variant PSP syndromes with presentations other than Richardson's syndrome. Objective : We aimed to provide an evidence‐ and consensus‐based revision of the clinical diagnostic criteria for PSP. Methods : We searched the PubMed, Cochrane, Medline, and PSYCInfo databases for articles published in English since 1996, using postmortem diagnosis or highly specific clinical criteria as the diagnostic standard. Second, we generated retrospective standardized clinical data from patients with autopsy‐confirmed PSP and control diseases. On this basis, diagnostic criteria were drafted, optimized in two modified Delphi evaluations, submitted to structured discussions with consensus procedures during a 2‐day meeting, and refined in three further Delphi rounds. Results : Defined clinical, imaging, laboratory, and genetic findings serve as mandatory basic features, mandatory exclusion criteria, or context‐dependent exclusion criteria. We identified four functional domains (ocular motor dysfunction, postural instability, akinesia, and cognitive dysfunction) as clinical predictors of PSP. Within each of these domains, we propose three clinical features that contribute different levels of diagnostic certainty. Specific combinations of these features define the diagnostic criteria, stratified by three degrees of diagnostic certainty (probable PSP, possible PSP, and suggestive of PSP). Clinical clues and imaging findings represent supportive features. Conclusions : Here, we present new criteria aimed to optimize early, sensitive, and specific clinical diagnosis of PSP on the basis of currently available evidence. © 2017 International Parkinson and Movement Disorder Society PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for PSP, have excellent specificity, but their sensitivity is limited for variant PSP syndromes with presentations other than Richardson's syndrome. We aimed to provide an evidence- and consensus-based revision of the clinical diagnostic criteria for PSP. We searched the PubMed, Cochrane, Medline, and PSYCInfo databases for articles published in English since 1996, using postmortem diagnosis or highly specific clinical criteria as the diagnostic standard. Second, we generated retrospective standardized clinical data from patients with autopsy-confirmed PSP and control diseases. On this basis, diagnostic criteria were drafted, optimized in two modified Delphi evaluations, submitted to structured discussions with consensus procedures during a 2-day meeting, and refined in three further Delphi rounds. Defined clinical, imaging, laboratory, and genetic findings serve as mandatory basic features, mandatory exclusion criteria, or context-dependent exclusion criteria. We identified four functional domains (ocular motor dysfunction, postural instability, akinesia, and cognitive dysfunction) as clinical predictors of PSP. Within each of these domains, we propose three clinical features that contribute different levels of diagnostic certainty. Specific combinations of these features define the diagnostic criteria, stratified by three degrees of diagnostic certainty (probable PSP, possible PSP, and suggestive of PSP). Clinical clues and imaging findings represent supportive features. Here, we present new criteria aimed to optimize early, sensitive, and specific clinical diagnosis of PSP on the basis of currently available evidence. © 2017 International Parkinson and Movement Disorder Society. |
| Author | Gelpi, Ellen Krismer, Florian Nestor, Peter Schellenberg, Gerard D. Bhatia, Kailash P. Meissner, Wassilios G. Pantelyat, Alexander Swieten, John C. Whitwell, Jennifer L. Giese, Armin Arzberger, Thomas Kassubek, Jan Wenning, Gregor K. Mollenhauer, Brit Ferguson, Leslie Oertel, Wolfgang H. Stamelou, Maria Levin, Johannes Rowe, James B. van Eimeren, Thilo Dodel, Richard Poewe, Werner van Swieten, John Englund, Elisabet Bordelon, Yvette Müller, Ulrich Höglinger, Günter U. Dickson, Dennis W. Compta, Yaroslau Colosimo, Carlo Rabinovici, Gil Kurz, Caroline Seppi, Klaus Lang, Anthony E. Eimeren, Thilo Golbe, Lawrence I. Boxer, Adam L. Josephs, Keith A. Lorenzl, Stefan Troakes, Claire Respondek, Gesine Corvol, Jean‐Christophe Kurz, Carolin Antonini, Angelo Morris, Huw R. Litvan, Irene Grossman, Murray Nilsson, Christer Rajput, Alex Irwin, David J. |
| AuthorAffiliation | Department of Neurology, Technische Universität München, Munich, Germany |
| AuthorAffiliation_xml | – name: Department of Neurology, Technische Universität München, Munich, Germany – name: 26 Sorbonne Universités, UPMC Univ Paris 06; and INSERM UMRS_1127, CIC_1422; and CNRS UMR_7225; and AP-HP; and ICM, Hôpital Pitié-Salpêtrière, Département des maladies du système nerveux, Paris, France – name: 39 Memory and Aging Center, Department of Neurology, University of California, San Francisco, California, USA – name: 2 German Center for Neurodegenerative Diseases (DZNE), Munich, Germany – name: 9 Department of Clinical Sciences, Division of Neurology, Lund University, Lund, Sweden – name: 32 Department of Neurology, Ludwig-Maximilians-Universitat, Munich, Germany – name: 15 Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France – name: 38 Department of Neurology, Philipps Universitat, Marburg, Germany – name: 43 Department of Neurology, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA – name: 16 CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France – name: 19 Division of Neurology, Royal University Hospital, University of Saskatchewan, Saskatoon, SK, Canada – name: 41 Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA – name: 13 Neurological Tissue Bank of the Biobank - Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, Barcelona, Spain – name: 14 Frontotemporal Degeneration Center, Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA – name: 4 Department of Psychiatry, Ludwig-Maximilians-Universitat, Munich, Germany – name: 30 Department of Neurology, University of Ulm, Ulm, Germany – name: 23 Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, Queen Square, London, United Kingdom – name: 40 Department of Clinical Neurosciences, Cambridge University, Cambridge, United Kingdom – name: 42 Departments of Nuclear Medicine and Neurology, University of Cologne, Cologne, Germany – name: 5 Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA – name: 12 Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden – name: 7 Paracelsus-Elena Klinik, Kassel, Germany, and University Medical Center Gottingen, Institute of Neuropathology, Gottingen, Germany – name: 28 Mayo Clinic, Jacksonville, Florida, USA – name: 33 Institute of Nursing Science and Practice, Paracelsus Medical University, Salzburg, Austria – name: 1 Department of Neurology, Technische Universitat Munchen, Munich, Germany – name: 11 Center for Neuropathology and Prion Research, Ludwig-Maximilians-Universitat, Munich, Germany – name: 3 Second Department of Neurology, Attikon University Hospital, University of Athens, Athens, Greece – name: 27 Department of Neurology, Santa Maria University Hospital of Terni, Terni, Italy – name: 36 Department of Clinical Neuroscience, UCL Institute of Neurology, London, United Kingdom – name: 29 Department of Geriatric Medicine, University Hospital Essen, Essen, Germany – name: 6 Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson’s Disease, Toronto Western Hospital, Toronto, Canada – name: 10 Department of Radiology, Mayo Clinic, Rochester, Minnesoya, USA – name: 17 Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, Bordeaux, France – name: 31 Department of Neurology, Medical University Innsbruck, Innsbruck, Austria – name: 34 Department of Neurology, Hospital Agatharied, Agatharied, Germany – name: 37 German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany – name: 35 Department of Palliative Medicine, Munich University Hospital, LMU Munich, Munich, Germany – name: 22 Parkinson and Movement Disorders Unit, IRCCS Hospital San Camillo, Venice, and Department of Neurosciences, Padova University, Padova, Italy – name: 25 Parkinson’s Disease & Movement Disorders Unit, Neurology Service, Hospital Clinic/IDIBAPS/University of Barcelona, Barcelona, Catalonia, Spain – name: 44 Department of Neurology, University of California, San Diego, California, USA – name: 24 Department of Neurology, University of California, Los Angeles, California, USA – name: 8 Institute of Human Genetics, Giessen, Germany – name: 18 Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA – name: 20 Department of Neurology, Erasmus Medical Centre, Rotterdam, The Netherlands – name: 21 London Neurodegenerative Diseases Brain Bank, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, United Kingdom |
| Author_xml | – sequence: 1 givenname: Günter U. orcidid: 0000-0001-7587-6187 surname: Höglinger fullname: Höglinger, Günter U. email: guenter.hoeglinger@dzne.de organization: German Center for Neurodegenerative Diseases (DZNE) – sequence: 2 givenname: Gesine surname: Respondek fullname: Respondek, Gesine organization: German Center for Neurodegenerative Diseases (DZNE) – sequence: 3 givenname: Maria orcidid: 0000-0003-1668-9925 surname: Stamelou fullname: Stamelou, Maria organization: Attikon University Hospital, University of Athens – sequence: 4 givenname: Carolin surname: Kurz fullname: Kurz, Carolin organization: Ludwig‐Maximilians‐Universität – sequence: 5 givenname: Keith A. surname: Josephs fullname: Josephs, Keith A. organization: Mayo Clinic – sequence: 6 givenname: Anthony E. surname: Lang fullname: Lang, Anthony E. organization: Toronto Western Hospital – sequence: 7 givenname: Brit surname: Mollenhauer fullname: Mollenhauer, Brit organization: Paracelsus‐Elena Klinik, Kassel, Germany, and University Medical Center Göttingen, Institute of Neuropathology – sequence: 8 givenname: Ulrich surname: Müller fullname: Müller, Ulrich organization: Institute of Human Genetics – sequence: 9 givenname: Christer surname: Nilsson fullname: Nilsson, Christer organization: Lund University – sequence: 10 givenname: Jennifer L. surname: Whitwell fullname: Whitwell, Jennifer L. organization: Mayo Clinic – sequence: 11 givenname: Thomas surname: Arzberger fullname: Arzberger, Thomas organization: Ludwig‐Maximilians‐Universität – sequence: 12 givenname: Elisabet surname: Englund fullname: Englund, Elisabet organization: Division of Oncology and Pathology, Lund University – sequence: 13 givenname: Ellen surname: Gelpi fullname: Gelpi, Ellen organization: Universitat de Barcelona, IDIBAPS – sequence: 14 givenname: Armin surname: Giese fullname: Giese, Armin organization: Ludwig‐Maximilians‐Universität – sequence: 15 givenname: David J. surname: Irwin fullname: Irwin, David J. organization: Department of Neurology, University of Pennsylvania – sequence: 16 givenname: Wassilios G. orcidid: 0000-0003-2172-7527 surname: Meissner fullname: Meissner, Wassilios G. organization: Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux – sequence: 17 givenname: Alexander surname: Pantelyat fullname: Pantelyat, Alexander organization: Johns Hopkins University – sequence: 18 givenname: Alex surname: Rajput fullname: Rajput, Alex organization: Royal University Hospital, University of Saskatchewan – sequence: 19 givenname: John C. surname: Swieten fullname: Swieten, John C. organization: Erasmus Medical Centre – sequence: 20 givenname: Claire surname: Troakes fullname: Troakes, Claire organization: Institute of Psychiatry, Psychology and Neuroscience, Kings College London – sequence: 21 givenname: Angelo surname: Antonini fullname: Antonini, Angelo organization: IRCCS Hospital San Camillo, Venice, and Department of Neurosciences, Padova University – sequence: 22 givenname: Kailash P. orcidid: 0000-0001-8185-286X surname: Bhatia fullname: Bhatia, Kailash P. organization: UCL Institute of Neurology – sequence: 23 givenname: Yvette surname: Bordelon fullname: Bordelon, Yvette organization: University of California – sequence: 24 givenname: Yaroslau surname: Compta fullname: Compta, Yaroslau organization: Neurology Service, Hospital Clinic/IDIBAPS/University of Barcelona – sequence: 25 givenname: Jean‐Christophe surname: Corvol fullname: Corvol, Jean‐Christophe organization: Sorbonne Universités, UPMC Univ Paris 06; and INSERM UMRS_1127, CIC_1422; and CNRS UMR_7225; and AP‐HP; and ICM, Hôpital Pitié‐Salpêtrière, Département des maladies du système nerveux – sequence: 26 givenname: Carlo surname: Colosimo fullname: Colosimo, Carlo organization: Santa Maria University Hospital of Terni – sequence: 27 givenname: Dennis W. surname: Dickson fullname: Dickson, Dennis W. organization: Mayo Clinic – sequence: 28 givenname: Richard surname: Dodel fullname: Dodel, Richard organization: University Hospital Essen – sequence: 29 givenname: Leslie surname: Ferguson fullname: Ferguson, Leslie organization: Royal University Hospital, University of Saskatchewan – sequence: 30 givenname: Murray surname: Grossman fullname: Grossman, Murray organization: Department of Neurology, University of Pennsylvania – sequence: 31 givenname: Jan surname: Kassubek fullname: Kassubek, Jan organization: University of Ulm – sequence: 32 givenname: Florian surname: Krismer fullname: Krismer, Florian organization: Medical University Innsbruck – sequence: 33 givenname: Johannes surname: Levin fullname: Levin, Johannes organization: Ludwig‐Maximilians‐Universität – sequence: 34 givenname: Stefan surname: Lorenzl fullname: Lorenzl, Stefan organization: Munich University Hospital – sequence: 35 givenname: Huw R. surname: Morris fullname: Morris, Huw R. organization: UCL Institute of Neurology – sequence: 36 givenname: Peter surname: Nestor fullname: Nestor, Peter organization: German Center for Neurodegenerative Diseases (DZNE) – sequence: 37 givenname: Wolfgang H. surname: Oertel fullname: Oertel, Wolfgang H. organization: Philipps Universität – sequence: 38 givenname: Werner surname: Poewe fullname: Poewe, Werner organization: Medical University Innsbruck – sequence: 39 givenname: Gil surname: Rabinovici fullname: Rabinovici, Gil organization: Department of Neurology, University of California – sequence: 40 givenname: James B. surname: Rowe fullname: Rowe, James B. organization: Cambridge University – sequence: 41 givenname: Gerard D. surname: Schellenberg fullname: Schellenberg, Gerard D. organization: Perelman School of Medicine, University of Pennsylvania – sequence: 42 givenname: Klaus surname: Seppi fullname: Seppi, Klaus organization: Medical University Innsbruck – sequence: 43 givenname: Thilo surname: Eimeren fullname: Eimeren, Thilo organization: University of Cologne – sequence: 44 givenname: Gregor K. surname: Wenning fullname: Wenning, Gregor K. organization: Medical University Innsbruck – sequence: 45 givenname: Adam L. surname: Boxer fullname: Boxer, Adam L. organization: Department of Neurology, University of California – sequence: 46 givenname: Lawrence I. surname: Golbe fullname: Golbe, Lawrence I. organization: Rutgers Robert Wood Johnson Medical School – sequence: 47 givenname: Irene surname: Litvan fullname: Litvan, Irene organization: University of California – sequence: 49 givenname: Adam L. surname: Boxer fullname: Boxer, Adam L. – sequence: 50 givenname: Alex surname: Rajput fullname: Rajput, Alex – sequence: 51 givenname: Alexander surname: Pantelyat fullname: Pantelyat, Alexander – sequence: 52 givenname: Angelo surname: Antonini fullname: Antonini, Angelo – sequence: 53 givenname: Anthony E. surname: Lang fullname: Lang, Anthony E. – sequence: 54 givenname: Armin surname: Giese fullname: Giese, Armin – sequence: 55 givenname: Brit surname: Mollenhauer fullname: Mollenhauer, Brit – sequence: 56 givenname: Carlo surname: Colosimo fullname: Colosimo, Carlo – sequence: 57 givenname: Caroline surname: Kurz fullname: Kurz, Caroline – sequence: 58 givenname: Christer surname: Nilsson fullname: Nilsson, Christer – sequence: 59 givenname: Claire surname: Troakes fullname: Troakes, Claire – sequence: 60 givenname: David J. surname: Irwin fullname: Irwin, David J. – sequence: 61 givenname: Dennis W. surname: Dickson fullname: Dickson, Dennis W. – sequence: 62 givenname: Ellen surname: Gelpi fullname: Gelpi, Ellen – sequence: 63 givenname: Florian surname: Krismer fullname: Krismer, Florian – sequence: 64 givenname: Gerard D. surname: Schellenberg fullname: Schellenberg, Gerard D. – sequence: 65 givenname: Gesine surname: Respondek fullname: Respondek, Gesine – sequence: 66 givenname: Gil surname: Rabinovici fullname: Rabinovici, Gil – sequence: 67 givenname: Gregor K. surname: Wenning fullname: Wenning, Gregor K. – sequence: 68 givenname: Günter U. surname: Höglinger fullname: Höglinger, Günter U. – sequence: 69 givenname: Huw R. surname: Morris fullname: Morris, Huw R. – sequence: 70 givenname: Irene surname: Litvan fullname: Litvan, Irene – sequence: 71 givenname: James B. surname: Rowe fullname: Rowe, James B. – sequence: 72 givenname: Jan surname: Kassubek fullname: Kassubek, Jan – sequence: 73 givenname: Jean‐Christophe surname: Corvol fullname: Corvol, Jean‐Christophe – sequence: 74 givenname: Jennifer L. surname: Whitwell fullname: Whitwell, Jennifer L. – sequence: 75 givenname: Johannes surname: Levin fullname: Levin, Johannes – sequence: 76 givenname: John surname: van Swieten fullname: van Swieten, John – sequence: 77 givenname: Kailash P. surname: Bhatia fullname: Bhatia, Kailash P. – sequence: 78 givenname: Keith A. surname: Josephs fullname: Josephs, Keith A. – sequence: 79 givenname: Klaus surname: Seppi fullname: Seppi, Klaus – sequence: 80 givenname: Lawrence I. surname: Golbe fullname: Golbe, Lawrence I. – sequence: 81 givenname: Maria surname: Stamelou fullname: Stamelou, Maria – sequence: 82 givenname: Murray surname: Grossman fullname: Grossman, Murray – sequence: 83 givenname: Peter surname: Nestor fullname: Nestor, Peter – sequence: 84 givenname: Richard surname: Dodel fullname: Dodel, Richard – sequence: 85 givenname: Stefan surname: Lorenzl fullname: Lorenzl, Stefan – sequence: 86 givenname: Thilo surname: van Eimeren fullname: van Eimeren, Thilo – sequence: 87 givenname: Thomas surname: Arzberger fullname: Arzberger, Thomas – sequence: 88 givenname: Ulrich surname: Müller fullname: Müller, Ulrich – sequence: 89 givenname: Wassilios G. surname: Meissner fullname: Meissner, Wassilios G. – sequence: 90 givenname: Werner surname: Poewe fullname: Poewe, Werner – sequence: 91 givenname: Wolfgang H. surname: Oertel fullname: Oertel, Wolfgang H. – sequence: 92 givenname: Yaroslau surname: Compta fullname: Compta, Yaroslau – sequence: 93 givenname: Yvette surname: Bordelon fullname: Bordelon, Yvette |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28467028$$D View this record in MEDLINE/PubMed https://hal.science/hal-04591972$$DView record in HAL |
| BookMark | eNp1kk9v1DAQxS1URLeFA18A5UgPaW0njh0OSNXyp0iLOFBuSCM7nuwaJXGwk6322-N2t4UiOFmyf-_Nm_GckKPBD0jIS0bPGaX8orfxnFe1kk_IgomC5YoLeUQWVCmRF0yJY3IS4w9KGROsekaOuSorSblakO_Lzg2u0V1mnV4PPrqY-TYbg18HjNFtMYvzGPQwNx3qkI26i7s32fUGs95vscdhSsrog8WQRd84nHZZE9yEwenn5GmbeHxxOE_Jtw_vr5dX-erLx0_Ly1XeiKKWeYpuja0UlsbWipZYlEabuqTSVMJSxqXEspWJ5VYwyiw1lS6lYappuda6OCV67xtvcJwNjMH1OuzAawejD5PuIDWT4jcb6GaICInqUteT80OEoqoF1lyCUkZAyYUBlYYDquWCS62sMjzVeLuvkaQ92iY1HpLvo1KPXga3gbXfgkgjF7xOBmd7g81fsqvLFdze0VLUrJZ8yxL7-lAs-J8zxgl6FxvsOj2gnyMwVZc154UQCX31Z64H5_svTsDFHmiCjzFgC42b7jpPMV0HjMLtEkFaIrhbot9JHxT3pv9iD-43rsPd_0H4_O7rXvELr47Ykw |
| CitedBy_id | crossref_primary_10_1016_S1474_4422_17_30157_6 crossref_primary_10_1016_j_ebiom_2025_105700 crossref_primary_10_1007_s11055_025_01821_z crossref_primary_10_1111_ncn3_12780 crossref_primary_10_1007_s11065_023_09597_0 crossref_primary_10_1055_s_0042_1744120 crossref_primary_10_1002_mds_30001 crossref_primary_10_1007_s00259_020_04785_z crossref_primary_10_1136_jnnp_2023_332862 crossref_primary_10_3389_fneur_2022_944806 crossref_primary_10_1007_s11940_024_00784_9 crossref_primary_10_1016_j_neuroimage_2024_120509 crossref_primary_10_1002_mds_30009 crossref_primary_10_1111_cen3_12759 crossref_primary_10_3389_fneur_2019_00116 crossref_primary_10_1002_mds_28399 crossref_primary_10_1136_jnnp_2021_326868 crossref_primary_10_1177_17562864241299347 crossref_primary_10_3348_kjr_2023_0920 crossref_primary_10_1016_j_parkreldis_2020_08_026 crossref_primary_10_1186_s13195_025_01748_0 crossref_primary_10_1002_mds_28395 crossref_primary_10_1055_a_2505_4660 crossref_primary_10_3389_fimmu_2025_1660587 crossref_primary_10_1016_j_parkreldis_2024_107226 crossref_primary_10_1002_mds_30257 crossref_primary_10_1016_j_parkreldis_2018_10_009 crossref_primary_10_1186_s40478_022_01388_7 crossref_primary_10_3233_JAD_190699 crossref_primary_10_3390_diagnostics12010012 crossref_primary_10_3233_JAD_201213 crossref_primary_10_1016_j_gaitpost_2020_02_007 crossref_primary_10_1016_j_clinph_2021_05_035 crossref_primary_10_3390_jcm9010040 crossref_primary_10_1016_j_parkreldis_2020_08_021 crossref_primary_10_1007_s13760_023_02352_5 crossref_primary_10_1111_jnp_12232 crossref_primary_10_1111_ggi_13775 crossref_primary_10_1136_jnnp_2022_330152 crossref_primary_10_1016_j_parkreldis_2021_10_007 crossref_primary_10_1111_nan_12710 crossref_primary_10_1007_s00259_020_04817_8 crossref_primary_10_1016_j_ncl_2024_12_006 crossref_primary_10_1002_dad2_12544 crossref_primary_10_1002_mds_30019 crossref_primary_10_1038_s41531_024_00786_z crossref_primary_10_1002_mds_27057 crossref_primary_10_1002_ana_25516 crossref_primary_10_3389_fneur_2019_00101 crossref_primary_10_1016_j_jocn_2020_05_005 crossref_primary_10_1007_s00062_023_01377_w crossref_primary_10_1007_s00415_025_12894_8 crossref_primary_10_1007_s10072_022_05919_x crossref_primary_10_1038_s41572_023_00447_0 crossref_primary_10_1111_ene_13412 crossref_primary_10_1177_02841851251315707 crossref_primary_10_1080_14737175_2022_2048648 crossref_primary_10_1186_s12974_024_03020_y crossref_primary_10_1002_mds_30225 crossref_primary_10_1177_17562864241267300 crossref_primary_10_1002_mds_30222 crossref_primary_10_1136_jnnp_2017_317839 crossref_primary_10_1002_mdc3_12807 crossref_primary_10_1186_s13195_020_00756_6 crossref_primary_10_1016_j_jns_2021_120018 crossref_primary_10_1016_j_jns_2023_120614 crossref_primary_10_1177_1877718X251343080 crossref_primary_10_1186_s13195_024_01553_1 crossref_primary_10_1016_j_jagp_2020_07_011 crossref_primary_10_3233_VES_210147 crossref_primary_10_1016_j_parkreldis_2018_02_004 crossref_primary_10_1097_WCO_0000000000000836 crossref_primary_10_1111_neup_12890 crossref_primary_10_1016_j_brainresbull_2025_111476 crossref_primary_10_1016_j_parkreldis_2025_107980 crossref_primary_10_1016_j_parkreldis_2021_11_020 crossref_primary_10_1111_neup_12894 crossref_primary_10_1212_WNL_0000000000200108 crossref_primary_10_1111_ene_15603 crossref_primary_10_3233_JAD_215616 crossref_primary_10_3233_JAD_221060 crossref_primary_10_1007_s41999_019_00211_2 crossref_primary_10_3233_ACS_220007 crossref_primary_10_1016_j_ncl_2024_05_008 crossref_primary_10_1016_j_nicl_2022_102950 crossref_primary_10_3389_fnagi_2021_720634 crossref_primary_10_3389_fnagi_2022_969875 crossref_primary_10_1016_j_parkreldis_2020_07_008 crossref_primary_10_3390_cells9010002 crossref_primary_10_1016_j_parkreldis_2023_105801 crossref_primary_10_1080_13554794_2018_1527368 crossref_primary_10_3390_medicina61040701 crossref_primary_10_1002_mdc3_13906 crossref_primary_10_1007_s00259_024_06741_7 crossref_primary_10_1007_s10072_021_05746_6 crossref_primary_10_1016_j_parkreldis_2018_11_022 crossref_primary_10_1038_s41598_024_81050_5 crossref_primary_10_1007_s00415_021_10585_8 crossref_primary_10_1186_s41824_024_00205_9 crossref_primary_10_1007_s00415_025_13256_0 crossref_primary_10_1038_s41531_023_00610_0 crossref_primary_10_3233_JAD_180409 crossref_primary_10_1177_1877718X251343094 crossref_primary_10_1016_j_ijrobp_2023_09_010 crossref_primary_10_1007_s10072_019_04216_4 crossref_primary_10_1007_s12031_017_0983_0 crossref_primary_10_1016_j_parkreldis_2021_01_003 crossref_primary_10_3389_fnagi_2023_1298307 crossref_primary_10_1016_j_ejmp_2022_04_016 crossref_primary_10_1016_j_clinph_2023_07_011 crossref_primary_10_1111_cns_70549 crossref_primary_10_1177_13872877251314199 crossref_primary_10_1016_j_nbd_2025_107052 crossref_primary_10_1002_mds_29287 crossref_primary_10_1111_neup_12868 crossref_primary_10_1038_s41591_020_0762_2 crossref_primary_10_1186_s40035_019_0160_1 crossref_primary_10_1017_cjn_2022_332 crossref_primary_10_1097_WAD_0000000000000339 crossref_primary_10_1111_cns_13527 crossref_primary_10_1159_000530075 crossref_primary_10_1016_j_parkreldis_2024_107025 crossref_primary_10_1007_s00415_023_11871_3 crossref_primary_10_1016_j_parkreldis_2025_107324 crossref_primary_10_1002_mds_30290 crossref_primary_10_1007_s15202_017_1822_4 crossref_primary_10_1007_s00702_025_03022_x crossref_primary_10_1016_j_bbi_2023_11_018 crossref_primary_10_3389_fnagi_2021_675739 crossref_primary_10_1016_j_nicl_2019_101899 crossref_primary_10_1007_s00415_022_11556_3 crossref_primary_10_1016_j_neubiorev_2025_106310 crossref_primary_10_1111_neup_12876 crossref_primary_10_1148_radiol_2020200028 crossref_primary_10_3233_JPD_191744 crossref_primary_10_1002_mds_28188 crossref_primary_10_1080_13554794_2021_1879869 crossref_primary_10_1016_j_bandl_2023_105314 crossref_primary_10_1016_j_jns_2023_122840 crossref_primary_10_1016_j_jns_2025_123617 crossref_primary_10_1016_j_parkreldis_2025_107772 crossref_primary_10_1038_s41467_022_28896_3 crossref_primary_10_1002_mds_30261 crossref_primary_10_1016_j_parkreldis_2020_08_014 crossref_primary_10_1044_2022_AJSLP_22_00148 crossref_primary_10_1371_journal_pone_0234265 crossref_primary_10_3390_biomedicines13071624 crossref_primary_10_1002_brb3_2344 crossref_primary_10_1002_mds_30027 crossref_primary_10_1186_s40478_019_0687_5 crossref_primary_10_1044_2022_AJSLP_22_00140 crossref_primary_10_3390_diagnostics13040783 crossref_primary_10_1016_j_parkreldis_2020_08_013 crossref_primary_10_1038_s41591_024_02937_4 crossref_primary_10_1186_s40035_023_00374_w crossref_primary_10_1177_1877718X251359212 crossref_primary_10_1016_j_nbd_2025_107076 crossref_primary_10_1016_j_parkreldis_2018_01_001 crossref_primary_10_1097_RLU_0000000000005141 crossref_primary_10_1177_13872877251317683 crossref_primary_10_1186_s12883_019_1539_4 crossref_primary_10_1016_j_parkreldis_2024_107251 crossref_primary_10_1016_j_parkreldis_2025_107301 crossref_primary_10_1016_j_parkreldis_2020_08_004 crossref_primary_10_3389_fneur_2022_873925 crossref_primary_10_1212_NXI_0000000000000866 crossref_primary_10_1016_j_jns_2025_123602 crossref_primary_10_1136_jnnp_2020_323487 crossref_primary_10_1016_j_nicl_2022_102999 crossref_primary_10_1016_j_parkreldis_2021_01_015 crossref_primary_10_1176_appi_neuropsych_20240128 crossref_primary_10_1177_1971400921998968 crossref_primary_10_4103_aian_aian_604_23 crossref_primary_10_1007_s13760_021_01629_x crossref_primary_10_1016_j_parkreldis_2020_09_039 crossref_primary_10_1186_s12929_021_00775_x crossref_primary_10_1038_s41531_022_00389_6 crossref_primary_10_1159_000479110 crossref_primary_10_1111_neup_12853 crossref_primary_10_1002_mds_29299 crossref_primary_10_1007_s00415_025_12983_8 crossref_primary_10_1007_s40336_020_00360_6 crossref_primary_10_1002_mdc3_13085 crossref_primary_10_1007_s00455_023_10560_7 crossref_primary_10_1212_CPJ_0000000000000959 crossref_primary_10_1016_j_neures_2023_05_004 crossref_primary_10_1212_WNL_0000000000200750 crossref_primary_10_1080_13803395_2019_1572073 crossref_primary_10_1136_jnnp_2021_328646 crossref_primary_10_1126_scitranslmed_abo6889 crossref_primary_10_3389_fneur_2022_894617 crossref_primary_10_1007_s10072_025_08292_7 crossref_primary_10_1007_s12311_021_01239_6 crossref_primary_10_1097_MD_0000000000016603 crossref_primary_10_1186_s42269_023_01052_7 crossref_primary_10_1016_j_parkreldis_2018_12_006 crossref_primary_10_1055_s_0041_1726354 crossref_primary_10_1007_s40263_018_0551_3 crossref_primary_10_1055_s_0041_1726355 crossref_primary_10_1016_j_parkreldis_2018_12_008 crossref_primary_10_3390_brainsci15010088 crossref_primary_10_1017_S1355617721000692 crossref_primary_10_1038_s41380_018_0342_8 crossref_primary_10_1080_13854046_2019_1670865 crossref_primary_10_1371_journal_pone_0279315 crossref_primary_10_3233_JAD_200987 crossref_primary_10_3390_brainsci12091126 crossref_primary_10_1007_s00401_025_02898_z crossref_primary_10_1016_j_parkreldis_2025_107352 crossref_primary_10_3233_JAD_231025 crossref_primary_10_1001_jamanetworkopen_2021_1290 crossref_primary_10_1002_mdc3_70304 crossref_primary_10_1044_2018_AJSLP_17_0227 crossref_primary_10_1007_s00415_023_12006_4 crossref_primary_10_1186_s13256_021_03139_z crossref_primary_10_1007_s10072_023_07107_x crossref_primary_10_1080_14656566_2019_1598377 crossref_primary_10_1002_mdc3_14187 crossref_primary_10_1212_CPJ_0000000000000704 crossref_primary_10_3389_fnagi_2023_1119070 crossref_primary_10_1016_j_bspc_2025_107659 crossref_primary_10_1186_s40035_021_00275_w crossref_primary_10_1016_j_prdoa_2025_100310 crossref_primary_10_1038_s41598_022_14532_z crossref_primary_10_1016_j_conctc_2023_101165 crossref_primary_10_1002_mdc3_14182 crossref_primary_10_1002_alz_13433 crossref_primary_10_1016_j_prdoa_2025_100305 crossref_primary_10_1007_s00115_018_0590_5 crossref_primary_10_1016_j_cca_2024_119975 crossref_primary_10_1038_s41598_024_73777_y crossref_primary_10_1177_11206721221148952 crossref_primary_10_1016_j_parkreldis_2020_09_019 crossref_primary_10_1186_s40478_023_01655_1 crossref_primary_10_1136_bmjno_2023_000553 crossref_primary_10_1002_ana_25911 crossref_primary_10_1007_s00415_022_11347_w crossref_primary_10_1080_14737159_2020_1731306 crossref_primary_10_3390_biom12040576 crossref_primary_10_1136_bmjno_2021_000214 crossref_primary_10_1002_mdc3_70338 crossref_primary_10_1111_ncn3_12721 crossref_primary_10_3390_diagnostics12102421 crossref_primary_10_1038_s43587_023_00478_y crossref_primary_10_1016_j_jalz_2017_12_008 crossref_primary_10_3390_biom10040497 crossref_primary_10_1186_s40035_019_0164_x crossref_primary_10_1016_j_neuron_2020_11_005 crossref_primary_10_1155_2023_3771601 crossref_primary_10_1016_j_jocn_2020_06_008 crossref_primary_10_1002_brb3_2547 crossref_primary_10_3389_fnagi_2018_00326 crossref_primary_10_3390_diagnostics15080945 crossref_primary_10_3892_mmr_2022_12604 crossref_primary_10_1038_s41598_024_74035_x crossref_primary_10_1111_neup_12805 crossref_primary_10_2967_jnumed_124_268754 crossref_primary_10_7759_cureus_83588 crossref_primary_10_1016_j_parkreldis_2024_107047 crossref_primary_10_1136_jnnp_2021_327788 crossref_primary_10_1002_mdc3_70321 crossref_primary_10_1186_s13195_022_01093_6 crossref_primary_10_1002_syn_70010 crossref_primary_10_1002_brb3_1448 crossref_primary_10_1002_mdc3_13070 crossref_primary_10_1007_s00415_021_10846_6 crossref_primary_10_1093_brain_awy180 crossref_primary_10_1016_j_clineuro_2024_108492 crossref_primary_10_1016_j_euroneuro_2018_11_679 crossref_primary_10_1016_S1474_4422_23_00447_7 crossref_primary_10_1016_j_parkreldis_2023_105408 crossref_primary_10_1007_s00702_025_02930_2 crossref_primary_10_1212_WNL_0000000000209793 crossref_primary_10_1007_s00455_019_10073_2 crossref_primary_10_1093_brain_awy178 crossref_primary_10_1016_j_nicl_2024_103727 crossref_primary_10_1016_j_pneurobio_2019_101644 crossref_primary_10_7759_cureus_15641 crossref_primary_10_1093_brain_awaa305 crossref_primary_10_1016_j_cortex_2022_07_015 crossref_primary_10_1016_j_parkreldis_2023_105883 crossref_primary_10_3389_fneur_2022_861585 crossref_primary_10_3390_biomedicines10071728 crossref_primary_10_1080_09593985_2022_2032509 crossref_primary_10_1007_s00415_024_12662_0 crossref_primary_10_1016_j_bcp_2022_114979 crossref_primary_10_1111_neup_12815 crossref_primary_10_3390_diagnostics13101682 crossref_primary_10_1016_j_cortex_2025_01_011 crossref_primary_10_1212_WNL_0000000000201647 crossref_primary_10_1002_mdc3_70357 crossref_primary_10_1212_NXI_0000000000000699 crossref_primary_10_1080_17460441_2023_2200245 crossref_primary_10_1186_s12883_019_1402_7 crossref_primary_10_1016_j_parkreldis_2023_105808 crossref_primary_10_1016_j_parkreldis_2023_105807 crossref_primary_10_3233_JAD_181152 crossref_primary_10_1016_j_neubiorev_2020_02_023 crossref_primary_10_1016_j_cortex_2018_09_023 crossref_primary_10_1007_s00415_020_10230_w crossref_primary_10_1002_alz_14558 crossref_primary_10_3233_ADR_230168 crossref_primary_10_1016_j_jns_2022_120514 crossref_primary_10_1038_s41598_022_06663_0 crossref_primary_10_3390_diagnostics13132192 crossref_primary_10_3390_vision9010010 crossref_primary_10_1002_dad2_12512 crossref_primary_10_3389_fimmu_2021_753856 crossref_primary_10_1007_s00259_022_06104_0 crossref_primary_10_1002_dad2_12517 crossref_primary_10_1212_cont_0000000000001607 crossref_primary_10_1002_mdc3_14140 crossref_primary_10_3389_fnins_2022_964715 crossref_primary_10_1007_s00415_023_11791_2 crossref_primary_10_1002_mdc3_70346 crossref_primary_10_1007_s10072_020_04290_z crossref_primary_10_3389_fneur_2023_1195576 crossref_primary_10_3389_fnins_2025_1580078 crossref_primary_10_1002_alz_14566 crossref_primary_10_1111_ene_16041 crossref_primary_10_1080_14737175_2025_2546867 crossref_primary_10_1212_WNL_0000000000004859 crossref_primary_10_1016_j_neurol_2020_02_008 crossref_primary_10_1212_CON_0000000000000751 crossref_primary_10_4103_aian_aian_1096_21 crossref_primary_10_3389_fnagi_2025_1569302 crossref_primary_10_1016_j_imbio_2025_152892 crossref_primary_10_1002_ana_27297 crossref_primary_10_1016_j_neurol_2019_09_010 crossref_primary_10_1007_s00221_023_06633_6 crossref_primary_10_1007_s00415_019_09463_1 crossref_primary_10_1002_mdc3_70134 crossref_primary_10_3389_fneur_2024_1386608 crossref_primary_10_3389_fneur_2021_674495 crossref_primary_10_1111_ggi_13582 crossref_primary_10_3233_JAD_220587 crossref_primary_10_31083_j_fbl2901012 crossref_primary_10_1016_S1634_7072_24_49601_3 crossref_primary_10_1212_WNL_0000000000209585 crossref_primary_10_1002_alz_13686 crossref_primary_10_1002_mds_27964 crossref_primary_10_1016_j_parkreldis_2023_105835 crossref_primary_10_1002_alz_14531 crossref_primary_10_1186_s12883_019_1270_1 crossref_primary_10_1016_j_neurobiolaging_2021_01_016 crossref_primary_10_1212_WNL_0000000000210108 crossref_primary_10_1002_mdc3_14348 crossref_primary_10_1002_mdc3_14346 crossref_primary_10_2967_jnumed_124_268956 crossref_primary_10_3389_fnagi_2018_00123 crossref_primary_10_3389_fimmu_2024_1458713 crossref_primary_10_1159_000494348 crossref_primary_10_1148_ryai_240181 crossref_primary_10_1007_s00702_025_03004_z crossref_primary_10_3389_fneur_2020_00847 crossref_primary_10_1016_j_parkreldis_2021_03_002 crossref_primary_10_1016_j_parkreldis_2021_03_001 crossref_primary_10_1016_j_neurobiolaging_2019_08_030 crossref_primary_10_1016_j_jns_2025_123683 crossref_primary_10_1212_WNL_0000000000008197 crossref_primary_10_3389_fneur_2024_1476488 crossref_primary_10_3389_fpsyg_2021_539555 crossref_primary_10_1016_j_parkreldis_2023_105848 crossref_primary_10_3389_fimmu_2022_852215 crossref_primary_10_3390_diseases13040119 crossref_primary_10_1007_s00415_020_10241_7 crossref_primary_10_1016_j_parkreldis_2023_105847 crossref_primary_10_1080_07317115_2019_1694115 crossref_primary_10_1007_s00415_023_11629_x crossref_primary_10_3389_fnagi_2025_1608631 crossref_primary_10_1016_j_cortex_2022_12_015 crossref_primary_10_1007_s00415_019_09672_8 crossref_primary_10_1038_s41582_024_00961_z crossref_primary_10_1177_0891988721993545 crossref_primary_10_1002_alz_70171 crossref_primary_10_1016_j_jocn_2025_111099 crossref_primary_10_1016_j_neuroimage_2022_119763 crossref_primary_10_1002_mdc3_70037 crossref_primary_10_1007_s10072_024_07952_4 crossref_primary_10_1038_s41598_025_02020_z crossref_primary_10_1016_j_nbd_2024_106686 crossref_primary_10_1038_s41380_022_01612_9 crossref_primary_10_1007_s10072_018_3437_8 crossref_primary_10_1016_j_neurobiolaging_2017_10_010 crossref_primary_10_1002_mds_29924 crossref_primary_10_1007_s10072_019_04010_2 crossref_primary_10_1016_j_jocn_2021_11_003 crossref_primary_10_1007_s12035_018_1426_9 crossref_primary_10_1523_JNEUROSCI_0808_23_2023 crossref_primary_10_1007_s00415_024_12551_6 crossref_primary_10_1016_j_parkreldis_2020_12_010 crossref_primary_10_3390_brainsci11101331 crossref_primary_10_1080_01616412_2023_2203612 crossref_primary_10_1016_j_parkreldis_2023_105454 crossref_primary_10_1002_ana_27265 crossref_primary_10_1007_s00115_018_0568_3 crossref_primary_10_3389_fneur_2018_00265 crossref_primary_10_4103_aian_aian_703_22 crossref_primary_10_1038_s41467_024_55442_0 crossref_primary_10_1159_000505590 crossref_primary_10_1038_s41531_025_01082_0 crossref_primary_10_1093_brain_awac471 crossref_primary_10_1111_nan_70026 crossref_primary_10_1016_j_neulet_2022_136675 crossref_primary_10_3390_brainsci10060399 crossref_primary_10_1016_j_cger_2019_09_014 crossref_primary_10_1016_j_prdoa_2025_100394 crossref_primary_10_1159_000504006 crossref_primary_10_1016_j_jrras_2024_101015 crossref_primary_10_1038_s41531_022_00392_x crossref_primary_10_1080_13554794_2020_1732427 crossref_primary_10_1002_mds_28822 crossref_primary_10_7759_cureus_47313 crossref_primary_10_1111_febs_14866 crossref_primary_10_3389_fnagi_2019_00249 crossref_primary_10_1002_mdc3_13366 crossref_primary_10_1007_s00428_024_03781_0 crossref_primary_10_1111_bpa_13286 crossref_primary_10_1002_alz_14482 crossref_primary_10_1007_s00415_022_11136_5 crossref_primary_10_1007_s00234_019_02183_3 crossref_primary_10_3390_medicina59040720 crossref_primary_10_1002_mdc3_70058 crossref_primary_10_1016_j_prdoa_2025_100380 crossref_primary_10_1016_j_jns_2019_116627 crossref_primary_10_1002_mdc3_70053 crossref_primary_10_1007_s00234_020_02500_1 crossref_primary_10_1007_s00415_019_09330_z crossref_primary_10_1007_s00415_019_09363_4 crossref_primary_10_1016_j_prdoa_2025_100389 crossref_primary_10_3389_fnagi_2021_703984 crossref_primary_10_3233_NRE_220235 crossref_primary_10_1111_ene_16370 crossref_primary_10_1093_arclin_acad081 crossref_primary_10_1016_j_cortex_2019_02_013 crossref_primary_10_1016_j_nicl_2022_103022 crossref_primary_10_3390_ijms241813676 crossref_primary_10_1002_mdc3_13334 crossref_primary_10_1007_s12311_018_0955_0 crossref_primary_10_1002_mdc3_13339 crossref_primary_10_1093_brain_awaa276 crossref_primary_10_1038_s41598_019_44234_y crossref_primary_10_1002_mdc3_13354 crossref_primary_10_1038_s41531_022_00304_z crossref_primary_10_1016_j_jns_2024_122896 crossref_primary_10_3389_fneur_2020_598763 crossref_primary_10_3389_fneur_2024_1477493 crossref_primary_10_3390_brainsci14020181 crossref_primary_10_1002_mds_29936 crossref_primary_10_1038_s41591_020_0755_1 crossref_primary_10_1186_s13550_019_0558_x crossref_primary_10_1007_s00259_018_4024_1 crossref_primary_10_1016_j_neulet_2020_134826 crossref_primary_10_3390_jpm10040274 crossref_primary_10_3390_ijms26157410 crossref_primary_10_1016_j_matpr_2021_06_044 crossref_primary_10_1016_j_nbd_2022_105819 crossref_primary_10_1136_bmjno_2022_000352 crossref_primary_10_1007_s00221_025_07031_w crossref_primary_10_3389_fneur_2020_603161 crossref_primary_10_1002_mds_29932 crossref_primary_10_1016_j_parkreldis_2020_11_004 crossref_primary_10_1016_j_parkreldis_2023_105483 crossref_primary_10_1186_s40478_023_01674_y crossref_primary_10_1093_arclin_acad079 crossref_primary_10_1093_brain_awab111 crossref_primary_10_3233_JPD_202033 crossref_primary_10_3390_ijms21238948 crossref_primary_10_3390_brainsci11010119 crossref_primary_10_3390_biom11101484 crossref_primary_10_1016_j_neuroimage_2025_121001 crossref_primary_10_1177_13872877251316804 crossref_primary_10_3390_biom13020218 crossref_primary_10_1007_s00415_025_13171_4 crossref_primary_10_1007_s00415_020_09824_1 crossref_primary_10_1016_j_heliyon_2023_e20595 crossref_primary_10_1002_mds_27546 crossref_primary_10_1002_mds_27788 crossref_primary_10_1016_j_parkreldis_2023_105899 crossref_primary_10_3390_diagnostics12051204 crossref_primary_10_1016_j_parkreldis_2020_11_019 crossref_primary_10_1212_CON_0000000000001558 crossref_primary_10_1007_s00259_022_06087_y crossref_primary_10_1016_j_jns_2021_117478 crossref_primary_10_1016_j_jns_2021_117477 crossref_primary_10_3233_JAD_220718 crossref_primary_10_1002_mds_27786 crossref_primary_10_1136_jnnp_2021_327129 crossref_primary_10_1212_WNL_0000000000012639 crossref_primary_10_1016_j_nicl_2021_102913 crossref_primary_10_1016_j_parkreldis_2019_10_020 crossref_primary_10_1080_13854046_2022_2112296 crossref_primary_10_1016_j_prdoa_2025_100352 crossref_primary_10_1136_bcr_2018_226170 crossref_primary_10_1371_journal_pone_0325624 crossref_primary_10_1007_s00330_021_07979_7 crossref_primary_10_1038_s41582_025_01136_0 crossref_primary_10_3233_JPD_223374 crossref_primary_10_1002_mds_28624 crossref_primary_10_1186_s13195_025_01851_2 crossref_primary_10_3390_antiox12122104 crossref_primary_10_1002_mds_27778 crossref_primary_10_1002_mds_28867 crossref_primary_10_1016_j_nbd_2024_106493 crossref_primary_10_1007_s00415_024_12816_0 crossref_primary_10_1007_s10072_022_06166_w crossref_primary_10_1016_j_nicl_2022_103030 crossref_primary_10_1007_s00415_022_11253_1 crossref_primary_10_1016_j_parkreldis_2021_06_006 crossref_primary_10_1002_alz_70378 crossref_primary_10_1038_s41531_025_00951_y crossref_primary_10_1111_ane_13136 crossref_primary_10_1002_acn3_50907 crossref_primary_10_1002_mdc3_13326 crossref_primary_10_1038_s41531_021_00273_9 crossref_primary_10_1186_s12987_025_00663_8 crossref_primary_10_1016_j_parkreldis_2021_05_002 crossref_primary_10_1111_ane_13372 crossref_primary_10_1111_neup_13015 crossref_primary_10_3389_fnagi_2021_635896 crossref_primary_10_1038_s41591_020_01198_1 crossref_primary_10_1007_s00259_022_05964_w crossref_primary_10_3390_muscles1030015 crossref_primary_10_1002_acn3_52097 crossref_primary_10_1016_j_compbiomed_2024_107951 crossref_primary_10_3390_biomedicines12081781 crossref_primary_10_1097_RLU_0000000000003409 crossref_primary_10_25259_JNRP_263_2024 crossref_primary_10_1111_ene_16320 crossref_primary_10_1016_j_dscb_2025_100192 crossref_primary_10_3390_ijms22147292 crossref_primary_10_1016_j_prdoa_2025_100339 crossref_primary_10_1007_s00415_021_10511_y crossref_primary_10_1044_2022_JSLHR_22_00177 crossref_primary_10_1097_WCO_0000000000001175 crossref_primary_10_3390_brainsci11070879 crossref_primary_10_1186_s12877_023_04564_z crossref_primary_10_1002_mds_29740 crossref_primary_10_1007_s00259_018_4035_y crossref_primary_10_1093_brain_awad105 crossref_primary_10_1038_s41598_021_96443_z crossref_primary_10_1007_s00415_024_12344_x crossref_primary_10_1007_s00259_024_06637_6 crossref_primary_10_1177_02841851241254746 crossref_primary_10_1016_S1474_4422_20_30485_3 crossref_primary_10_1093_brain_awab163 crossref_primary_10_1111_bpa_13219 crossref_primary_10_3389_fneur_2019_01180 crossref_primary_10_1016_j_clinph_2020_06_018 crossref_primary_10_1007_s13760_018_0993_x crossref_primary_10_1002_ana_25060 crossref_primary_10_1111_ene_16578 crossref_primary_10_1038_s41398_022_02114_6 crossref_primary_10_1212_WNL_0000000000011528 crossref_primary_10_1002_mds_28406 crossref_primary_10_1055_a_1207_0515 crossref_primary_10_1007_s11682_023_00789_z crossref_primary_10_2217_nmt_2023_0011 crossref_primary_10_3390_biom14101213 crossref_primary_10_1038_s41591_023_02358_9 crossref_primary_10_1007_s00415_021_10522_9 crossref_primary_10_1093_brain_awz189 crossref_primary_10_1177_0269215519877235 crossref_primary_10_3233_JPD_223392 crossref_primary_10_1097_WCO_0000000000001163 crossref_primary_10_1016_S1634_7072_24_49340_9 crossref_primary_10_1016_j_clineuro_2025_108919 crossref_primary_10_1016_j_intimp_2022_109445 crossref_primary_10_1016_j_neuroimage_2020_117193 crossref_primary_10_1002_mdc3_13788 crossref_primary_10_1007_s10072_024_07887_w crossref_primary_10_1007_s12149_025_02081_0 crossref_primary_10_3390_brainsci15060587 crossref_primary_10_1016_j_parkreldis_2023_105293 crossref_primary_10_1007_s00415_025_12897_5 crossref_primary_10_1093_jnen_nlz141 crossref_primary_10_1038_s41582_021_00541_5 crossref_primary_10_1093_brain_awae263 crossref_primary_10_3389_fnins_2021_723227 crossref_primary_10_1097_RLU_0000000000002977 crossref_primary_10_1111_pcn_13680 crossref_primary_10_1016_j_parkreldis_2018_04_005 crossref_primary_10_1080_17582024_2025_2481817 crossref_primary_10_1038_s41582_020_0330_x crossref_primary_10_1007_s00259_025_07199_x crossref_primary_10_1177_25424823251329804 crossref_primary_10_4103_aian_AIAN_1047_20 crossref_primary_10_1002_mds_29527 crossref_primary_10_1080_14789450_2025_2519466 crossref_primary_10_1093_jnen_nlad052 crossref_primary_10_1186_s40734_019_0081_2 crossref_primary_10_1002_pcn5_24 crossref_primary_10_1080_14737175_2019_1636648 crossref_primary_10_1007_s00702_025_02904_4 crossref_primary_10_1002_mds_28672 crossref_primary_10_1002_mds_29760 crossref_primary_10_1007_s00415_021_10762_9 crossref_primary_10_1016_j_parkreldis_2023_105296 crossref_primary_10_1093_brain_awae016 crossref_primary_10_1136_bmjopen_2023_077772 crossref_primary_10_3389_fneur_2021_648548 crossref_primary_10_1212_CPJ_0000000000001003 crossref_primary_10_1093_brain_awae011 crossref_primary_10_1111_neup_13001 crossref_primary_10_1186_s40478_023_01572_3 crossref_primary_10_1212_WNL_0000000000005069 crossref_primary_10_3389_fnagi_2022_977100 crossref_primary_10_1007_s10072_023_06644_9 crossref_primary_10_1186_s40035_023_00367_9 crossref_primary_10_1007_s00259_020_04969_7 crossref_primary_10_1016_j_parkreldis_2025_107805 crossref_primary_10_1016_j_bbrc_2024_149620 crossref_primary_10_1016_S1474_4422_20_30394_X crossref_primary_10_3390_ijms232314554 crossref_primary_10_1016_j_parkreldis_2021_07_007 crossref_primary_10_1080_02687038_2018_1545991 crossref_primary_10_3233_JAD_215327 crossref_primary_10_1002_mdc3_12678 crossref_primary_10_1212_WNL_0000000000007249 crossref_primary_10_1016_j_sleep_2022_09_025 crossref_primary_10_1016_j_nicl_2020_102408 crossref_primary_10_1093_brain_awad396 crossref_primary_10_1212_WNL_0000000000201389 crossref_primary_10_1212_WNL_0000000000006383 crossref_primary_10_1007_s13760_023_02358_z crossref_primary_10_1016_j_brainresbull_2024_111046 crossref_primary_10_1002_mdc3_12892 crossref_primary_10_1016_j_parkreldis_2019_10_012 crossref_primary_10_4103_aian_aian_512_24 crossref_primary_10_1007_s00401_024_02834_7 crossref_primary_10_1007_s11920_019_1058_4 crossref_primary_10_1111_ene_70248 crossref_primary_10_1177_1533317520922383 crossref_primary_10_2196_52831 crossref_primary_10_1080_08164622_2025_2458747 crossref_primary_10_3389_fneur_2021_702052 crossref_primary_10_1016_j_clineuro_2020_106088 crossref_primary_10_1002_mds_28217 crossref_primary_10_4103_AOMD_AOMD_18_22 crossref_primary_10_1002_pcn5_178 crossref_primary_10_1136_practneurol_2020_002794 crossref_primary_10_1038_s41598_020_76339_0 crossref_primary_10_1016_j_remnie_2025_500159 crossref_primary_10_1111_jon_70062 crossref_primary_10_1186_s13550_023_01025_x crossref_primary_10_1016_j_dadm_2019_01_011 crossref_primary_10_1080_13543784_2023_2233892 crossref_primary_10_1111_jon_70063 crossref_primary_10_1002_alz_14297 crossref_primary_10_1007_s00415_024_12747_w crossref_primary_10_1002_mdc3_13733 crossref_primary_10_1038_s41531_021_00262_y crossref_primary_10_1093_brain_awae233 crossref_primary_10_1016_j_remn_2025_500159 crossref_primary_10_3389_fneur_2021_571800 crossref_primary_10_1080_13554794_2025_2560858 crossref_primary_10_1186_s40035_024_00407_y crossref_primary_10_3390_life12070947 crossref_primary_10_1111_ene_15447 crossref_primary_10_1002_mdc3_13990 crossref_primary_10_1038_s41380_024_02809_w crossref_primary_10_3389_fnins_2019_00298 crossref_primary_10_1002_dad2_70031 crossref_primary_10_1016_j_radcr_2022_05_007 crossref_primary_10_1016_j_jns_2020_117108 crossref_primary_10_1038_s41598_021_88877_2 crossref_primary_10_1016_j_cmpb_2025_108778 crossref_primary_10_3390_biomedicines12112510 crossref_primary_10_1093_jnen_nlad025 crossref_primary_10_3233_JPD_171254 crossref_primary_10_1002_mdc3_12894 crossref_primary_10_1002_mds_29774 crossref_primary_10_3389_fneur_2018_00692 crossref_primary_10_3389_fneur_2025_1609823 crossref_primary_10_3233_JPD_223357 crossref_primary_10_1097_WCO_0000000000000677 crossref_primary_10_1002_mdc3_13987 crossref_primary_10_3892_etm_2022_11411 crossref_primary_10_1007_s10072_020_04635_8 crossref_primary_10_1212_WNL_0000000000214040 crossref_primary_10_3390_app15158134 crossref_primary_10_1007_s10072_021_05246_7 crossref_primary_10_1038_s41531_025_00868_6 crossref_primary_10_1080_13554794_2024_2377206 crossref_primary_10_4103_aian_aian_642_21 crossref_primary_10_1007_s00259_018_4031_2 crossref_primary_10_1016_j_parkreldis_2025_107839 crossref_primary_10_1111_ene_13673 crossref_primary_10_1002_mdc3_13959 crossref_primary_10_1007_s00415_022_11086_y crossref_primary_10_1002_mds_29329 crossref_primary_10_3389_fpsyt_2019_00075 crossref_primary_10_1002_mdc3_13958 crossref_primary_10_1148_radiol_2019190406 crossref_primary_10_1136_jnnp_2019_321354 crossref_primary_10_1212_CON_0000000000001158 crossref_primary_10_3389_fneur_2020_00180 crossref_primary_10_1007_s00259_020_05152_8 crossref_primary_10_1002_mdc3_13710 crossref_primary_10_1002_mds_29322 crossref_primary_10_3389_fneur_2019_01125 crossref_primary_10_1212_CPJ_0000000000200240 crossref_primary_10_1007_s00455_021_10251_1 crossref_primary_10_1016_j_parkreldis_2021_08_009 crossref_primary_10_1002_mds_28470 crossref_primary_10_1007_s13311_020_00888_5 crossref_primary_10_3233_JAD_201139 crossref_primary_10_1055_s_0041_1741495 crossref_primary_10_1111_ene_15864 crossref_primary_10_1186_s12883_023_03151_4 crossref_primary_10_1080_14737175_2019_1562337 crossref_primary_10_1111_neup_12590 crossref_primary_10_3233_JAD_201132 crossref_primary_10_1002_mdc3_12879 crossref_primary_10_1007_s00401_022_02479_4 crossref_primary_10_3390_ijms25084269 crossref_primary_10_1111_cns_70146 crossref_primary_10_1111_nan_12757 crossref_primary_10_1007_s10072_023_07021_2 crossref_primary_10_1002_mdc3_13965 crossref_primary_10_1093_brain_awaf135 crossref_primary_10_1002_hbm_26342 crossref_primary_10_1177_13872877251376694 crossref_primary_10_1016_S1474_4422_24_00275_8 crossref_primary_10_1093_brain_awaf132 crossref_primary_10_1038_s44321_025_00229_z crossref_primary_10_31083_j_jin2004108 crossref_primary_10_1002_mds_28263 crossref_primary_10_1007_s13311_023_01380_6 crossref_primary_10_3390_ijms25115607 crossref_primary_10_3390_diagnostics12071671 crossref_primary_10_1007_s13760_024_02697_5 crossref_primary_10_1007_s12311_022_01472_7 crossref_primary_10_1016_j_neuropsychologia_2021_107772 crossref_primary_10_1177_09727531251321234 crossref_primary_10_1002_mds_29587 crossref_primary_10_3389_fnagi_2022_998255 crossref_primary_10_3389_fneur_2018_00483 crossref_primary_10_1002_mds_28011 crossref_primary_10_3390_ijms22158100 crossref_primary_10_1007_s00415_017_8579_8 crossref_primary_10_1038_s41591_023_02449_7 crossref_primary_10_1002_ana_25447 crossref_primary_10_1007_s10072_019_04208_4 crossref_primary_10_1038_s41531_024_00738_7 crossref_primary_10_1007_s00259_021_05391_3 crossref_primary_10_1007_s10072_022_06160_2 crossref_primary_10_1093_brain_awae032 crossref_primary_10_1002_mds_28010 crossref_primary_10_1093_brain_awac091 crossref_primary_10_1002_mds_29581 crossref_primary_10_1053_j_semnuclmed_2020_12_003 crossref_primary_10_3389_fneur_2021_694872 crossref_primary_10_1007_s11682_020_00432_1 crossref_primary_10_1016_j_nicl_2019_102009 crossref_primary_10_1111_pcn_13854 crossref_primary_10_1038_s41467_023_42305_3 crossref_primary_10_1002_mdc3_12616 crossref_primary_10_1002_mdc3_13706 crossref_primary_10_1002_mdc3_13707 crossref_primary_10_1111_nan_12535 crossref_primary_10_3389_fnsys_2025_1466809 crossref_primary_10_1002_mds_29339 crossref_primary_10_1038_s41531_020_00141_y crossref_primary_10_1016_j_jagp_2024_03_002 crossref_primary_10_1136_pn_2023_003772 crossref_primary_10_3389_fneur_2023_1212185 crossref_primary_10_1186_s40035_022_00311_3 crossref_primary_10_1002_ana_26540 crossref_primary_10_1016_j_parkreldis_2023_105287 crossref_primary_10_1002_mds_29338 crossref_primary_10_3233_JPD_223553 crossref_primary_10_1002_mds_28007 crossref_primary_10_1038_s41598_023_44427_6 crossref_primary_10_1093_brain_awae269 crossref_primary_10_3389_fnins_2023_1240709 crossref_primary_10_1002_mds_29336 crossref_primary_10_3390_brainsci14100991 crossref_primary_10_1177_0284185120920793 crossref_primary_10_1136_bmjopen_2025_102668 crossref_primary_10_1002_mds_27196 crossref_primary_10_1007_s10072_021_05601_8 crossref_primary_10_1017_cjn_2022_69 crossref_primary_10_3390_neurolint16010001 crossref_primary_10_1007_s00415_019_09566_9 crossref_primary_10_1080_02687038_2020_1787732 crossref_primary_10_1007_s00415_020_09883_4 crossref_primary_10_1016_j_nicl_2019_101722 crossref_primary_10_1186_s13073_022_01035_9 crossref_primary_10_1002_acn3_70147 crossref_primary_10_1016_j_compbiomed_2024_109518 crossref_primary_10_1016_S1474_4422_21_00214_3 crossref_primary_10_3390_brainsci12070949 crossref_primary_10_1017_cjn_2021_216 crossref_primary_10_1038_s41531_021_00249_9 crossref_primary_10_3389_fneur_2020_635341 crossref_primary_10_1038_s41467_021_23687_8 crossref_primary_10_3390_diagnostics13111967 crossref_primary_10_3390_ijms21061948 crossref_primary_10_1016_j_parkreldis_2021_09_008 crossref_primary_10_1007_s00415_020_09992_0 crossref_primary_10_1016_j_jns_2022_120436 crossref_primary_10_3389_fneur_2022_1018206 crossref_primary_10_1002_mdc3_12940 crossref_primary_10_1097_WCO_0000000000000502 crossref_primary_10_1016_j_jns_2023_120718 crossref_primary_10_1002_mds_28038 crossref_primary_10_1016_j_neurobiolaging_2021_07_007 crossref_primary_10_3233_JAD_170743 crossref_primary_10_3390_ijms252111663 crossref_primary_10_1002_mds_29362 crossref_primary_10_1016_S1474_4422_20_30314_8 crossref_primary_10_1186_s40035_024_00426_9 crossref_primary_10_1055_a_1099_9380 crossref_primary_10_1177_08919887231164357 crossref_primary_10_1007_s40120_022_00420_1 crossref_primary_10_1016_j_parkreldis_2024_107108 crossref_primary_10_1212_WNL_0000000000010814 crossref_primary_10_1016_j_neurobiolaging_2021_07_004 crossref_primary_10_3389_fnins_2021_647783 crossref_primary_10_1186_s13024_024_00747_3 crossref_primary_10_1016_j_jns_2024_123280 crossref_primary_10_1002_dad2_12423 crossref_primary_10_1044_2023_JSLHR_22_00526 crossref_primary_10_1093_brain_awx347 crossref_primary_10_1002_ana_26962 crossref_primary_10_3390_brainsci14080805 crossref_primary_10_1002_mds_28060 crossref_primary_10_1002_hbm_24484 crossref_primary_10_3389_fneur_2022_905779 crossref_primary_10_1186_s12883_020_1608_8 crossref_primary_10_1038_s41598_023_42135_9 crossref_primary_10_3233_JAD_201105 crossref_primary_10_3389_fneur_2021_630153 crossref_primary_10_1080_14737175_2018_1489241 crossref_primary_10_1016_j_neulet_2023_137356 crossref_primary_10_1007_s00401_020_02160_8 crossref_primary_10_1016_S1474_4422_25_00157_7 crossref_primary_10_1038_s41531_024_00774_3 crossref_primary_10_1016_j_jns_2024_123292 crossref_primary_10_1038_s41598_024_53355_y crossref_primary_10_3389_fnins_2020_00893 crossref_primary_10_1016_j_parkreldis_2022_04_003 crossref_primary_10_1055_s_0043_1763511 crossref_primary_10_1007_s00415_020_10327_2 crossref_primary_10_1016_j_jns_2022_120415 crossref_primary_10_1016_j_parkreldis_2018_09_009 crossref_primary_10_1007_s12035_025_04890_w crossref_primary_10_1007_s00415_021_10936_5 crossref_primary_10_1016_S1634_7072_25_50692_X crossref_primary_10_1007_s00415_020_09870_9 crossref_primary_10_1097_WCO_0000000000000957 crossref_primary_10_1007_s00415_023_11892_y crossref_primary_10_1016_j_brs_2019_07_017 crossref_primary_10_1111_ene_14634 crossref_primary_10_1177_0271678X211018904 crossref_primary_10_4103_aian_aian_515_24 crossref_primary_10_2147_NDT_S474584 crossref_primary_10_1017_cjn_2024_31 crossref_primary_10_3390_brainsci14090859 crossref_primary_10_1002_mds_30112 crossref_primary_10_1007_s11910_018_0898_3 crossref_primary_10_1016_j_nicl_2019_101999 crossref_primary_10_1097_WAD_0000000000000479 crossref_primary_10_1007_s00259_025_07396_8 crossref_primary_10_3389_fnagi_2024_1518155 crossref_primary_10_1002_mds_29378 crossref_primary_10_1111_neup_12777 crossref_primary_10_1016_j_sleep_2025_106767 crossref_primary_10_1002_mds_27198 crossref_primary_10_1111_neup_12779 crossref_primary_10_1017_S1355617725101215 crossref_primary_10_1016_j_jns_2021_118054 crossref_primary_10_1016_j_jns_2025_123519 crossref_primary_10_1007_s00415_024_12391_4 crossref_primary_10_1016_j_parkreldis_2024_107155 crossref_primary_10_3389_fneur_2023_1330321 crossref_primary_10_4103_0028_3886_333499 crossref_primary_10_1111_ene_14800 crossref_primary_10_1371_journal_pone_0268337 crossref_primary_10_3389_fnagi_2023_1229491 crossref_primary_10_1186_s40478_020_01035_z crossref_primary_10_1002_mds_28087 crossref_primary_10_3389_fneur_2024_1464524 crossref_primary_10_1002_mds_29173 crossref_primary_10_1007_s00062_025_01564_x crossref_primary_10_1212_WNL_0000000000207901 crossref_primary_10_1093_bib_bbaa244 crossref_primary_10_1186_s13195_023_01296_5 crossref_primary_10_3390_cells10030656 crossref_primary_10_1016_j_jns_2022_120482 crossref_primary_10_3389_fnagi_2021_661284 crossref_primary_10_1007_s00415_022_11544_7 crossref_primary_10_1007_s00415_023_12136_9 crossref_primary_10_1007_s00391_019_01562_y crossref_primary_10_1017_S1355617718001030 crossref_primary_10_1002_alz_12414 crossref_primary_10_1155_ane_2674746 crossref_primary_10_3390_brainsci14040313 crossref_primary_10_1002_mdc3_12900 crossref_primary_10_1016_j_bbi_2024_03_018 crossref_primary_10_1016_j_parkreldis_2017_10_020 crossref_primary_10_3389_fneur_2020_572976 crossref_primary_10_1016_j_jns_2025_123502 crossref_primary_10_1016_j_mcna_2018_10_014 crossref_primary_10_3233_JAD_210226 crossref_primary_10_3390_s24206721 crossref_primary_10_1016_j_mednuc_2021_02_001 crossref_primary_10_1007_s00415_019_09324_x crossref_primary_10_1016_j_nicl_2024_103671 crossref_primary_10_1177_1877718X241298192 crossref_primary_10_1080_14737159_2024_2427625 crossref_primary_10_3390_jcm13195798 crossref_primary_10_1136_bmjopen_2021_055019 crossref_primary_10_1002_mds_28068 crossref_primary_10_1002_dad2_12229 crossref_primary_10_1007_s00415_023_11574_9 crossref_primary_10_1007_s00259_020_05168_0 crossref_primary_10_1007_s00415_024_12338_9 crossref_primary_10_1111_ene_13728 crossref_primary_10_1007_s11910_019_0966_3 crossref_primary_10_1002_mds_29194 crossref_primary_10_1002_brb3_3552 crossref_primary_10_1016_j_cct_2022_107058 crossref_primary_10_3390_cells10113064 crossref_primary_10_3390_diagnostics11091557 crossref_primary_10_1002_gps_5843 crossref_primary_10_1111_jon_12971 crossref_primary_10_3389_fnins_2024_1433465 crossref_primary_10_1007_s00259_020_04788_w crossref_primary_10_1007_s00702_025_02920_4 crossref_primary_10_3389_fneur_2025_1638852 crossref_primary_10_1007_s00401_025_02853_y crossref_primary_10_1016_j_clinph_2020_12_023 crossref_primary_10_1016_j_cobeha_2017_12_015 crossref_primary_10_1097_WCO_0000000000000521 crossref_primary_10_4103_aian_AIAN_611_20 crossref_primary_10_1186_s13550_019_0477_x crossref_primary_10_3390_jcm9082454 crossref_primary_10_3233_JAD_210023 crossref_primary_10_1002_ana_26930 crossref_primary_10_1212_WNL_0000000000201597 crossref_primary_10_1111_ncn3_12473 crossref_primary_10_1136_jnnp_2018_320151 crossref_primary_10_1007_s10072_023_06766_0 crossref_primary_10_1001_jamanetworkopen_2025_19919 crossref_primary_10_4103_0028_3886_284382 crossref_primary_10_1186_s13195_021_00841_4 crossref_primary_10_17816_ACEN_2018_2_5 crossref_primary_10_1007_s00702_025_02955_7 crossref_primary_10_1093_brain_awx327 crossref_primary_10_1186_s40478_025_02058_0 crossref_primary_10_3389_fneur_2020_00574 crossref_primary_10_3389_fneur_2020_00573 crossref_primary_10_1136_jnnp_2020_325549 crossref_primary_10_1016_j_nrleng_2019_03_027 crossref_primary_10_3389_fnagi_2022_917706 crossref_primary_10_1186_s13195_025_01778_8 crossref_primary_10_3390_biomedicines12102266 crossref_primary_10_1002_alz_14628 crossref_primary_10_1007_s00415_023_11824_w crossref_primary_10_3389_fneur_2022_827338 crossref_primary_10_1002_brb3_2884 crossref_primary_10_1016_j_nicl_2024_103642 crossref_primary_10_1016_j_parkreldis_2018_08_025 crossref_primary_10_1016_j_jns_2025_123391 crossref_primary_10_1038_s41598_021_82469_w crossref_primary_10_1111_neup_12707 crossref_primary_10_1080_14737175_2018_1519397 crossref_primary_10_1007_s10072_025_08184_w crossref_primary_10_3389_fneur_2022_955893 crossref_primary_10_1016_S1634_7072_24_49339_2 crossref_primary_10_1093_brain_awaa456 crossref_primary_10_1136_jnnp_2019_321954 crossref_primary_10_1016_j_ebiom_2021_103361 crossref_primary_10_1002_alz_70563 crossref_primary_10_1007_s00259_018_4019_y crossref_primary_10_1177_1877718X241291996 crossref_primary_10_1007_s00702_025_03005_y crossref_primary_10_3390_biomedicines12102257 crossref_primary_10_1038_s41582_020_0348_0 crossref_primary_10_1186_s13024_022_00586_0 crossref_primary_10_1038_s42003_024_06877_0 crossref_primary_10_3390_biomedicines13051009 crossref_primary_10_1016_j_parkreldis_2020_02_007 crossref_primary_10_1080_17549507_2023_2221407 crossref_primary_10_1016_j_parkreldis_2022_06_021 crossref_primary_10_1212_WNL_0000000000209453 crossref_primary_10_1002_alz_13551 crossref_primary_10_1212_WNL_0000000000209693 crossref_primary_10_1002_alz_13799 crossref_primary_10_1007_s11910_024_01365_8 crossref_primary_10_1093_brain_awz122 crossref_primary_10_3389_fneur_2019_00621 crossref_primary_10_1002_acn3_50948 crossref_primary_10_3390_a14020049 crossref_primary_10_1093_brain_awx189 crossref_primary_10_1093_braincomms_fcaf206 crossref_primary_10_1371_journal_pone_0223621 crossref_primary_10_1007_s00259_022_05804_x crossref_primary_10_1371_journal_pone_0243454 crossref_primary_10_3390_cells12242776 crossref_primary_10_1016_j_parkreldis_2019_02_014 crossref_primary_10_1097_RLU_0000000000005229 crossref_primary_10_1016_j_parkreldis_2019_02_012 crossref_primary_10_3390_diagnostics14232746 crossref_primary_10_1002_alz_14608 crossref_primary_10_3233_JAD_200890 crossref_primary_10_3389_fnmol_2021_720220 crossref_primary_10_1016_j_parkreldis_2022_06_011 crossref_primary_10_1016_j_parkreldis_2023_105516 crossref_primary_10_1186_s13195_024_01474_z crossref_primary_10_1016_j_jalz_2019_06_4956 crossref_primary_10_3389_fneur_2023_1208213 crossref_primary_10_1093_brain_awz157 crossref_primary_10_1055_s_0043_1764204 crossref_primary_10_3389_fnagi_2023_1294293 crossref_primary_10_1007_s11910_018_0819_5 crossref_primary_10_1136_pn_2020_002797 crossref_primary_10_1212_WNL_0000000000005610 crossref_primary_10_3389_fnagi_2024_1368539 crossref_primary_10_3390_life11060484 crossref_primary_10_3389_fneur_2021_791366 crossref_primary_10_1002_mdc3_14042 crossref_primary_10_1136_bmjno_2024_000946 crossref_primary_10_1007_s12311_023_01543_3 crossref_primary_10_1016_j_parkreldis_2024_106076 crossref_primary_10_1001_jamanetworkopen_2024_4266 crossref_primary_10_1007_s13760_023_02262_6 crossref_primary_10_1097_RLU_0000000000005457 crossref_primary_10_3390_biomedicines13030572 crossref_primary_10_1186_s13195_020_00585_7 crossref_primary_10_1007_s10072_019_03944_x crossref_primary_10_1016_j_parkreldis_2019_02_022 crossref_primary_10_1007_s00415_020_10360_1 crossref_primary_10_1016_j_sleep_2022_06_008 crossref_primary_10_1007_s10072_023_06628_9 crossref_primary_10_1136_bmjopen_2025_099577 crossref_primary_10_1093_brain_awaa428 crossref_primary_10_3389_fneur_2021_637176 crossref_primary_10_1007_s00401_018_1878_z crossref_primary_10_1016_j_parkreldis_2023_105768 crossref_primary_10_1016_j_heliyon_2023_e14824 crossref_primary_10_3233_JAD_180123 crossref_primary_10_1002_alz_13533 crossref_primary_10_1371_journal_pone_0253079 crossref_primary_10_1016_j_jns_2021_117366 crossref_primary_10_1016_j_parkreldis_2022_06_008 crossref_primary_10_1007_s00415_020_09900_6 crossref_primary_10_3390_jcm14072212 crossref_primary_10_1002_alz_70116 crossref_primary_10_21790_rvs_2024_026 crossref_primary_10_3390_diagnostics12020385 crossref_primary_10_1002_alz_70352 crossref_primary_10_1016_j_jns_2021_117363 crossref_primary_10_1016_j_parkreldis_2018_07_016 crossref_primary_10_1007_s40336_018_0297_4 crossref_primary_10_1155_2022_1746540 crossref_primary_10_1038_s41380_023_02188_8 crossref_primary_10_3390_diagnostics12123022 crossref_primary_10_1007_s12035_020_02035_9 crossref_primary_10_1016_j_parkreldis_2019_02_034 crossref_primary_10_1111_jon_13204 crossref_primary_10_3389_fneur_2021_664796 crossref_primary_10_1007_s00415_023_11946_1 crossref_primary_10_3389_fneur_2022_800298 crossref_primary_10_1212_WNL_0000000000004500 crossref_primary_10_1002_mdc3_13158 crossref_primary_10_1016_j_jad_2020_07_127 crossref_primary_10_3390_jcm11102701 crossref_primary_10_1016_j_parkreldis_2022_11_018 crossref_primary_10_3390_diagnostics13162711 crossref_primary_10_1002_alz_12494 crossref_primary_10_1016_j_parkreldis_2025_107272 crossref_primary_10_1016_j_parkreldis_2025_107273 crossref_primary_10_1016_j_parkreldis_2025_107289 crossref_primary_10_1080_17582024_2025_2514994 crossref_primary_10_4103_aian_aian_507_23 crossref_primary_10_1007_s00415_021_10889_9 crossref_primary_10_1002_mdc3_70221 crossref_primary_10_3233_JAD_220432 crossref_primary_10_1016_j_parkreldis_2020_01_019 crossref_primary_10_1002_mds_28901 crossref_primary_10_1186_s40673_021_00134_4 crossref_primary_10_3390_brainsci10070466 crossref_primary_10_1002_mds_27816 crossref_primary_10_1093_brain_awac428 crossref_primary_10_1177_00048674241312805 crossref_primary_10_1002_ana_27172 crossref_primary_10_1038_s41467_018_05325_y crossref_primary_10_1016_j_neurol_2018_07_001 crossref_primary_10_1016_j_neurol_2022_12_015 crossref_primary_10_1186_s13195_025_01712_y crossref_primary_10_3390_brainsci11060695 crossref_primary_10_1038_s41598_023_35758_5 crossref_primary_10_1111_ane_13653 crossref_primary_10_3233_JPD_240210 crossref_primary_10_1002_acn3_70121 crossref_primary_10_4103_aian_AIAN_71_21 crossref_primary_10_1038_s41531_021_00232_4 crossref_primary_10_1007_s11011_024_01342_7 crossref_primary_10_1016_j_ebiom_2023_104835 crossref_primary_10_1016_j_parkreldis_2022_05_006 crossref_primary_10_3390_neurolint15030066 crossref_primary_10_1002_acn3_50990 crossref_primary_10_1007_s00415_022_11442_y crossref_primary_10_1080_14656566_2024_2345734 crossref_primary_10_1007_s12035_025_05252_2 crossref_primary_10_1007_s00401_020_02210_1 crossref_primary_10_3390_ijms252313211 crossref_primary_10_1016_j_parkreldis_2017_12_016 crossref_primary_10_3389_fneur_2021_767480 crossref_primary_10_1080_13543784_2018_1460356 crossref_primary_10_3390_brainsci14070680 crossref_primary_10_3389_fneur_2021_736784 crossref_primary_10_3390_nu12072109 crossref_primary_10_1007_s00330_025_11440_4 crossref_primary_10_1007_s00415_025_13262_2 crossref_primary_10_1016_j_parkreldis_2022_05_014 crossref_primary_10_1007_s00401_020_02158_2 crossref_primary_10_1007_s00415_023_12009_1 crossref_primary_10_1002_mdc3_13396 crossref_primary_10_1007_s10072_022_06035_6 crossref_primary_10_3390_brainsci13081202 crossref_primary_10_1186_s12883_018_1072_x crossref_primary_10_1111_ene_15089 crossref_primary_10_3233_JAD_181012 crossref_primary_10_36290_neu_2017_085 crossref_primary_10_1016_j_parkreldis_2018_08_016 crossref_primary_10_1093_brain_awz344 crossref_primary_10_1093_brain_awac407 crossref_primary_10_1016_j_parkreldis_2023_105962 crossref_primary_10_1007_s00415_024_12752_z crossref_primary_10_1212_WNL_0000000000209478 crossref_primary_10_1212_CON_0000000000001506 crossref_primary_10_1002_mdc3_13001 crossref_primary_10_1002_mdc3_70153 crossref_primary_10_3389_fneur_2023_1100931 crossref_primary_10_1155_2021_3419907 crossref_primary_10_1002_acn3_51065 crossref_primary_10_1038_s41398_025_03345_z crossref_primary_10_1136_jnnp_2021_328120 crossref_primary_10_1002_mds_70017 crossref_primary_10_1007_s11910_018_0848_0 crossref_primary_10_5334_tohm_65 crossref_primary_10_1016_j_pmrj_2017_12_011 crossref_primary_10_1080_01677063_2025_2500953 crossref_primary_10_1369_00221554231158428 crossref_primary_10_1002_mds_29806 crossref_primary_10_3389_fnagi_2022_1003792 crossref_primary_10_1007_s00401_021_02402_3 crossref_primary_10_1097_RLU_0000000000005962 crossref_primary_10_1186_s13550_025_01210_0 crossref_primary_10_1002_mds_27621 crossref_primary_10_1002_brb3_70274 crossref_primary_10_1002_alz_70289 crossref_primary_10_1007_s10072_022_06296_1 crossref_primary_10_1055_a_1670_7111 crossref_primary_10_1016_j_nicl_2018_02_036 crossref_primary_10_1186_s12883_023_03466_2 crossref_primary_10_1186_s12883_025_04225_1 crossref_primary_10_1016_j_rcp_2023_10_003 crossref_primary_10_1016_j_ynirp_2025_100273 crossref_primary_10_1002_mdc3_13010 crossref_primary_10_3348_jksr_2022_0048 crossref_primary_10_1016_j_neuron_2020_09_042 crossref_primary_10_1002_brb3_1700 crossref_primary_10_1016_j_nicl_2023_103402 crossref_primary_10_1136_jnnp_2024_335723 crossref_primary_10_3233_JAD_215043 crossref_primary_10_1002_mds_28707 crossref_primary_10_1002_mds_27619 crossref_primary_10_1016_j_jns_2017_09_043 crossref_primary_10_3389_fneur_2023_1082060 crossref_primary_10_1097_01_JAA_0000718416_94952_6f crossref_primary_10_1002_mdc3_13489 crossref_primary_10_1016_j_parkreldis_2023_105345 crossref_primary_10_1093_brain_awab017 crossref_primary_10_1016_j_clinph_2021_08_012 crossref_primary_10_1016_j_jns_2020_117286 crossref_primary_10_1093_brain_awaa165 crossref_primary_10_1016_j_jns_2020_117293 crossref_primary_10_1016_j_nicl_2019_102152 crossref_primary_10_1136_jnnp_2021_328586 crossref_primary_10_1002_nbm_4795 crossref_primary_10_3389_fneur_2022_1081219 crossref_primary_10_1007_s00401_019_02035_7 crossref_primary_10_1001_jamaneurol_2024_5017 crossref_primary_10_1002_acn3_669 crossref_primary_10_1002_alz_14333 crossref_primary_10_1016_j_parkreldis_2019_08_007 crossref_primary_10_3390_ijms22094626 crossref_primary_10_1002_alz_14337 crossref_primary_10_1002_mds_27408 crossref_primary_10_1007_s00108_022_01444_3 crossref_primary_10_3389_fnagi_2020_00126 crossref_primary_10_1002_mdc3_13455 crossref_primary_10_1016_j_nbd_2022_105927 crossref_primary_10_1002_mds_27643 crossref_primary_10_1080_14728214_2019_1609450 crossref_primary_10_1111_jnc_15796 crossref_primary_10_1177_08919887211036189 crossref_primary_10_3390_ijms242015135 crossref_primary_10_1002_mds_28731 crossref_primary_10_1038_s41591_021_01455_x crossref_primary_10_1111_ane_13205 crossref_primary_10_3233_JAD_230676 crossref_primary_10_3390_brainsci14101012 crossref_primary_10_1212_cont_0000000000001558 crossref_primary_10_1007_s00259_024_06923_3 crossref_primary_10_1016_j_parkreldis_2019_09_032 crossref_primary_10_1016_j_nbd_2022_105947 crossref_primary_10_1002_alz_70082 crossref_primary_10_1016_j_parkreldis_2022_08_007 crossref_primary_10_1017_cjn_2018_367 crossref_primary_10_3390_jcm12082799 crossref_primary_10_1111_ene_16258 crossref_primary_10_1111_ene_16259 crossref_primary_10_1016_j_neucli_2024_102956 crossref_primary_10_1007_s00415_024_12617_5 crossref_primary_10_1016_j_jns_2018_03_023 crossref_primary_10_1002_mds_29814 crossref_primary_10_1111_jnc_15561 crossref_primary_10_1002_mds_27877 crossref_primary_10_3390_biomedicines9030230 crossref_primary_10_1002_mdc3_14315 crossref_primary_10_1016_j_nbd_2022_105937 crossref_primary_10_1002_mdc3_13466 crossref_primary_10_1002_mdc3_14313 crossref_primary_10_1002_mds_28721 crossref_primary_10_1093_brain_awaa383 crossref_primary_10_1002_mdc3_13227 crossref_primary_10_1002_mds_27872 crossref_primary_10_1212_WNL_0000000000007179 crossref_primary_10_1093_brain_awac161 crossref_primary_10_36290_neu_2024_051 crossref_primary_10_1002_mdc3_13442 crossref_primary_10_1007_s00401_018_1851_x crossref_primary_10_1016_j_neulet_2019_134564 crossref_primary_10_1136_bmjopen_2023_080475 crossref_primary_10_1212_CPJ_0000000000000919 crossref_primary_10_1038_s41531_020_00124_z crossref_primary_10_1002_mds_28517 crossref_primary_10_1007_s00259_022_05952_0 crossref_primary_10_1007_s00702_025_02960_w crossref_primary_10_1016_j_nicl_2023_103443 crossref_primary_10_1002_mds_28757 crossref_primary_10_1016_j_pjnns_2018_06_002 crossref_primary_10_1002_mds_28992 crossref_primary_10_1016_j_parkreldis_2019_07_012 crossref_primary_10_1055_s_0043_1764228 crossref_primary_10_1002_mdc3_13435 crossref_primary_10_1016_j_parkreldis_2019_07_010 crossref_primary_10_1093_brain_awac158 crossref_primary_10_1136_jnnp_2024_333590 crossref_primary_10_1177_11795735241259429 crossref_primary_10_1177_13872877241313145 crossref_primary_10_1186_s40035_025_00495_4 crossref_primary_10_3390_ijms26093927 crossref_primary_10_1002_alz_70248 crossref_primary_10_1002_alz_70485 crossref_primary_10_1016_j_parkreldis_2019_07_016 crossref_primary_10_1002_mds_27666 crossref_primary_10_1212_NXI_0000000000001137 crossref_primary_10_3389_fnagi_2022_848991 crossref_primary_10_1016_j_parkreldis_2020_03_003 crossref_primary_10_1038_s41531_022_00329_4 crossref_primary_10_1186_s13195_022_01094_5 crossref_primary_10_1016_j_parkreldis_2024_106975 crossref_primary_10_1016_j_parkreldis_2024_106978 crossref_primary_10_1111_ene_15346 crossref_primary_10_1136_bcr_2022_253820 crossref_primary_10_2463_mrms_mp_2024_0003 crossref_primary_10_3389_fnagi_2021_646440 crossref_primary_10_1136_bmjopen_2023_081317 crossref_primary_10_1002_mds_28988 crossref_primary_10_1212_WNL_0000000000209890 crossref_primary_10_1002_mds_27419 crossref_primary_10_1002_mds_28981 crossref_primary_10_1080_13543784_2022_2087179 crossref_primary_10_1016_j_jns_2021_117581 crossref_primary_10_1080_14737175_2021_1965879 crossref_primary_10_1097_ICU_0000000000000605 crossref_primary_10_4103_neurol_india_Neurol_India_D_24_00101 crossref_primary_10_1515_cclm_2023_0562 crossref_primary_10_1097_RLU_0000000000005700 crossref_primary_10_1016_j_neurobiolaging_2021_10_012 crossref_primary_10_1056_NEJMra2401857 crossref_primary_10_3390_jcm12206671 crossref_primary_10_1016_j_jagp_2024_12_005 crossref_primary_10_1016_j_jns_2018_04_016 crossref_primary_10_1002_alz_14377 crossref_primary_10_1002_brb3_1924 crossref_primary_10_1016_j_parkreldis_2020_04_006 crossref_primary_10_1016_j_parkreldis_2023_105313 crossref_primary_10_1080_09540261_2017_1396446 crossref_primary_10_1007_s00259_025_07478_7 crossref_primary_10_1001_jamanetworkopen_2022_9588 crossref_primary_10_1186_s40478_022_01436_2 crossref_primary_10_1002_alz_13042 crossref_primary_10_1002_mds_29866 crossref_primary_10_1093_brain_awaa196 crossref_primary_10_1136_jnnp_2020_324903 crossref_primary_10_1002_mdc3_13415 crossref_primary_10_1016_j_parkreldis_2019_07_009 crossref_primary_10_1093_brain_awab282 crossref_primary_10_1097_RLU_0000000000002424 crossref_primary_10_1186_s13195_021_00815_6 crossref_primary_10_1016_S1474_4422_21_00030_2 crossref_primary_10_1002_alz_70284 crossref_primary_10_1002_mdc3_12582 crossref_primary_10_1002_mdc3_12581 crossref_primary_10_1016_j_xcrm_2025_102207 crossref_primary_10_1002_mdc3_12584 crossref_primary_10_1093_cercor_bhac041 crossref_primary_10_1002_mdc3_13671 crossref_primary_10_1016_j_parkreldis_2024_106955 crossref_primary_10_1002_mds_70026 crossref_primary_10_1111_ene_16451 crossref_primary_10_1038_s41591_025_03890_6 crossref_primary_10_3988_jcn_2024_0517 crossref_primary_10_1007_s10072_025_08435_w crossref_primary_10_1038_s41598_023_30381_w crossref_primary_10_1093_jnen_nlac094 crossref_primary_10_3389_fnins_2022_755211 crossref_primary_10_1080_14737175_2019_1606715 crossref_primary_10_1007_s00115_023_01475_7 crossref_primary_10_1016_j_jocn_2019_06_025 crossref_primary_10_1016_j_parkreldis_2020_04_014 crossref_primary_10_1007_s00415_023_11976_9 crossref_primary_10_1016_j_parkreldis_2019_07_001 crossref_primary_10_1186_s13195_017_0331_1 crossref_primary_10_2147_EB_S384769 crossref_primary_10_1136_bcr_2018_227119 crossref_primary_10_1002_mds_29613 crossref_primary_10_1016_j_heliyon_2024_e34910 crossref_primary_10_1016_j_ebiom_2023_104456 crossref_primary_10_1111_bpa_12914 crossref_primary_10_1212_WNL_0000000000012727 crossref_primary_10_1002_mdc3_13881 crossref_primary_10_3389_fneur_2021_644064 crossref_primary_10_1007_s00415_018_8966_9 crossref_primary_10_1038_s41531_025_01030_y crossref_primary_10_1002_lary_28885 crossref_primary_10_1186_s40478_023_01584_z crossref_primary_10_3233_JAD_201047 crossref_primary_10_1186_s13195_021_00804_9 crossref_primary_10_1007_s00415_024_12419_9 crossref_primary_10_1007_s12311_022_01453_w crossref_primary_10_1007_s00415_023_12153_8 crossref_primary_10_1016_j_neurol_2023_02_070 crossref_primary_10_1097_WCO_0000000000000581 crossref_primary_10_1186_s13195_020_00753_9 crossref_primary_10_1002_trc2_12205 crossref_primary_10_1002_mdc3_13633 crossref_primary_10_3390_diseases13020039 crossref_primary_10_3390_ijms25158243 crossref_primary_10_1080_01658107_2024_2379423 crossref_primary_10_1212_WNL_0000000000201288 crossref_primary_10_1002_mds_29887 crossref_primary_10_1002_ana_26455 crossref_primary_10_1038_s41431_025_01872_3 crossref_primary_10_1016_S1474_4422_21_00283_0 crossref_primary_10_1038_s41531_024_00728_9 crossref_primary_10_1111_ene_15788 crossref_primary_10_1002_mdc3_12562 crossref_primary_10_1007_s10072_021_05594_4 crossref_primary_10_1111_ene_15781 crossref_primary_10_1515_revneuro_2020_0011 crossref_primary_10_1016_j_nicl_2020_102535 crossref_primary_10_1016_j_parkreldis_2020_06_030 crossref_primary_10_1080_14737175_2025_2515068 crossref_primary_10_3389_fcell_2023_1104393 crossref_primary_10_1007_s00415_024_12583_y crossref_primary_10_1044_2020_AJSLP_20_00126 crossref_primary_10_3389_fneur_2018_00319 crossref_primary_10_1007_s00259_019_04496_0 crossref_primary_10_1111_jnc_15944 crossref_primary_10_1002_mdc3_12796 crossref_primary_10_1001_jama_2025_7817 crossref_primary_10_1097_WCO_0000000000000578 crossref_primary_10_1136_jnnp_2018_318603 crossref_primary_10_1212_WNL_0000000000005175 crossref_primary_10_1016_j_neuropsychologia_2019_02_022 crossref_primary_10_1093_brain_awab097 crossref_primary_10_1097_RLU_0000000000004815 crossref_primary_10_1007_s10072_017_3206_0 crossref_primary_10_1212_WNL_0000000000011850 crossref_primary_10_1007_s00259_024_06954_w crossref_primary_10_1016_j_neurobiolaging_2023_01_015 crossref_primary_10_1093_jnen_nlz048 crossref_primary_10_1212_WNL_0000000000213499 crossref_primary_10_3233_JPD_202302 crossref_primary_10_1016_j_parkreldis_2019_07_030 crossref_primary_10_3389_fneur_2023_1259327 crossref_primary_10_1186_s12883_020_01692_6 crossref_primary_10_1002_mds_29421 crossref_primary_10_1002_mds_29420 crossref_primary_10_1007_s11910_021_01111_4 crossref_primary_10_1177_0271678X211031035 crossref_primary_10_1016_j_jns_2023_120696 crossref_primary_10_1177_10731911251339362 crossref_primary_10_1080_13554794_2018_1477963 crossref_primary_10_1136_jnnp_2017_317443 crossref_primary_10_1097_WNN_0000000000000289 crossref_primary_10_1186_s13024_021_00476_x crossref_primary_10_3233_JAD_190950 crossref_primary_10_1038_nrneurol_2017_96 crossref_primary_10_3390_ijms26031231 crossref_primary_10_36290_neu_2025_020 crossref_primary_10_1016_j_clineuro_2020_106196 crossref_primary_10_1111_ene_70134 crossref_primary_10_1007_s13311_021_01101_x crossref_primary_10_3389_fnagi_2020_563595 crossref_primary_10_1016_j_cortex_2020_12_019 crossref_primary_10_1212_CPJ_0000000000200157 crossref_primary_10_3390_antiox10071021 crossref_primary_10_1111_nan_12692 crossref_primary_10_1111_cns_70284 crossref_primary_10_1186_s13195_019_0562_4 crossref_primary_10_1002_alz_14185 crossref_primary_10_1016_S1474_4422_24_00274_6 crossref_primary_10_1016_j_disamonth_2024_101753 crossref_primary_10_3233_JAD_200151 crossref_primary_10_1016_j_brs_2019_05_017 crossref_primary_10_1007_s00415_018_9038_x crossref_primary_10_1053_j_sult_2020_08_011 crossref_primary_10_1007_s00330_017_5269_y crossref_primary_10_1002_alz_12802 crossref_primary_10_3390_life13081786 crossref_primary_10_1016_j_nicl_2021_102862 crossref_primary_10_1016_j_ynirp_2025_100247 crossref_primary_10_3390_biom11060845 crossref_primary_10_3389_fnagi_2022_804385 crossref_primary_10_1002_ana_25308 crossref_primary_10_1016_j_neurobiolaging_2020_04_006 crossref_primary_10_3389_fneur_2019_00398 crossref_primary_10_1212_CPJ_0000000000200360 crossref_primary_10_1002_mds_28356 crossref_primary_10_3390_biomedicines13061405 crossref_primary_10_1038_s41467_024_46603_2 crossref_primary_10_1038_s41398_025_03523_z crossref_primary_10_1212_WNL_0000000000008896 crossref_primary_10_1093_brain_awae174 crossref_primary_10_1111_pcn_13751 crossref_primary_10_1186_s12014_024_09507_3 crossref_primary_10_1212_WNL_0000000000209818 crossref_primary_10_4103_1673_5374_391180 crossref_primary_10_1016_S0140_6736_25_01294_2 crossref_primary_10_1111_ene_15505 crossref_primary_10_1007_s00234_019_02253_6 crossref_primary_10_3390_ijms26178278 crossref_primary_10_1002_mds_29431 crossref_primary_10_1007_s00415_023_11578_5 crossref_primary_10_1007_s00415_024_12350_z crossref_primary_10_1016_j_neuropsychologia_2020_107569 crossref_primary_10_3390_ijms25136882 crossref_primary_10_1002_mds_28348 crossref_primary_10_1002_mdc3_12756 crossref_primary_10_1038_s41467_023_44307_7 crossref_primary_10_3389_fnhum_2023_1082555 crossref_primary_10_1016_j_parkreldis_2025_107932 crossref_primary_10_1016_j_nicl_2019_102112 crossref_primary_10_1186_s13024_025_00882_5 crossref_primary_10_1016_S1634_7072_22_47094_2 crossref_primary_10_1136_practneurol_2019_002461 crossref_primary_10_1007_s10072_025_07996_0 crossref_primary_10_1186_s13550_021_00758_x crossref_primary_10_1007_s00330_023_09435_0 crossref_primary_10_1016_j_parkreldis_2025_107939 crossref_primary_10_1111_psyg_70069 crossref_primary_10_3389_fneur_2020_599384 crossref_primary_10_1097_01_NT_0000527326_97101_97 crossref_primary_10_1007_s10072_022_06119_3 crossref_primary_10_1016_j_clineuro_2023_107975 crossref_primary_10_1212_CPJ_0000000000200345 crossref_primary_10_1111_psyg_70063 crossref_primary_10_1002_mds_29222 crossref_primary_10_1212_WNL_0000000000207600 crossref_primary_10_3389_fneur_2022_821570 crossref_primary_10_1007_s10072_024_07833_w crossref_primary_10_1177_13872877251318011 crossref_primary_10_1007_s10072_022_06061_4 crossref_primary_10_1002_gps_5692 crossref_primary_10_1002_mds_28373 crossref_primary_10_1007_s00115_023_01544_x crossref_primary_10_1007_s00406_025_02013_z crossref_primary_10_7759_cureus_55436 crossref_primary_10_1038_s41586_021_03911_7 crossref_primary_10_1093_brain_awae391 crossref_primary_10_3389_fneur_2024_1460576 crossref_primary_10_3390_brainsci14090930 crossref_primary_10_1002_pcn5_70174 crossref_primary_10_1097_WAD_0000000000000396 crossref_primary_10_1155_2021_9990679 crossref_primary_10_1016_j_nicl_2021_102850 crossref_primary_10_3390_jcm13020465 crossref_primary_10_3389_fnagi_2022_851788 crossref_primary_10_1016_j_nicl_2021_102853 crossref_primary_10_1093_jnen_nlaa073 crossref_primary_10_31083_j_fbl2801021 crossref_primary_10_1080_03036758_2022_2101483 crossref_primary_10_1080_00207454_2020_1732965 crossref_primary_10_1007_s00415_024_12528_5 crossref_primary_10_1002_mds_28364 crossref_primary_10_1016_j_neurobiolaging_2020_04_016 crossref_primary_10_1002_mds_27038 crossref_primary_10_1002_trc2_12418 crossref_primary_10_1002_mdc3_13821 crossref_primary_10_1002_mds_29456 |
| Cites_doi | 10.1016/j.jns.2012.09.005 10.1002/mds.25327 10.1093/brain/awl078 10.1097/00005072-199601000-00010 10.1159/000068502 10.1002/mds.21612 10.1002/mds.22583 10.1212/WNL.44.11.2015 10.1186/s40478-016-0391-7 10.1002/mds.22977 10.1002/mds.26499 10.3988/jcn.2010.6.3.148 10.1001/archneur.1964.00460160003001 10.1212/01.wnl.0000191307.69661.c3 10.1016/j.parkreldis.2013.07.019 10.1002/ana.24844 10.1097/WCO.0b013e3283168ddd 10.1007/BF03161076 10.1093/brain/120.1.65 10.1212/WNL.47.1.1 10.1523/JNEUROSCI.2600-10.2011 10.1136/jnnp.60.6.615 10.1097/01.jnen.0000218446.38158.61 10.1016/j.parkreldis.2007.11.004 10.1212/WNL.53.6.1292 10.1093/brain/awq123 10.1002/mds.21698 10.1038/ng.859 10.1111/neup.12012 10.1212/01.wnl.0000267643.24870.26 10.1002/mds.10680 10.1093/brain/aww340 10.1111/nan.12208 10.1002/mds.10459 10.1002/ana.22424 10.1007/s00401-012-0983-7 10.1002/mds.20478 10.1001/jamaneurol.2013.3956 10.1080/13554794.2011.627345 10.1002/mds.10211 10.1002/mds.26054 10.1111/j.1440-1789.2009.01032.x 10.1111/nan.12037 10.1007/s00401-003-0682-5 10.1093/brain/awh488 10.1038/ncomms8247 |
| ContentType | Journal Article |
| Contributor | Gelpi, Ellen Krismer, Florian Nestor, Peter Schellenberg, Gerard D Pantelyat, Alexander Compta, Yaroslau Colosimo, Carlo Rabinovici, Gil Giese, Armin Lang, Anthony E Kurz, Caroline Whitwell, Jennifer L Seppi, Klaus Kassubek, Jan Arzberger, Thomas Golbe, Lawrence I Mollenhauer, Brit Lorenzl, Stefan Troakes, Claire Josephs, Keith A Respondek, Gesine Antonini, Angelo Litvan, Irene Levin, Johannes Stamelou, Maria Boxer, Adam L van Eimeren, Thilo Corvol, Jean-Christophe Dodel, Richard Wenning, Gregor K Morris, Huw R Poewe, Werner Rowe, James B Dickson, Dennis W van Swieten, John Grossman, Murray Nilsson, Christer Bhatia, Kailash P Irwin, David J Höglinger, Günter U Oertel, Wolfgang H Bordelon, Yvette Rajput, Alex Müller, Ulrich Meissner, Wassilios G |
| Contributor_xml | – sequence: 1 givenname: Adam L surname: Boxer fullname: Boxer, Adam L – sequence: 2 givenname: Alex surname: Rajput fullname: Rajput, Alex – sequence: 3 givenname: Alexander surname: Pantelyat fullname: Pantelyat, Alexander – sequence: 4 givenname: Angelo surname: Antonini fullname: Antonini, Angelo – sequence: 5 givenname: Anthony E surname: Lang fullname: Lang, Anthony E – sequence: 6 givenname: Armin surname: Giese fullname: Giese, Armin – sequence: 7 givenname: Brit surname: Mollenhauer fullname: Mollenhauer, Brit – sequence: 8 givenname: Carlo surname: Colosimo fullname: Colosimo, Carlo – sequence: 9 givenname: Caroline surname: Kurz fullname: Kurz, Caroline – sequence: 10 givenname: Christer surname: Nilsson fullname: Nilsson, Christer – sequence: 11 givenname: Claire surname: Troakes fullname: Troakes, Claire – sequence: 12 givenname: David J surname: Irwin fullname: Irwin, David J – sequence: 13 givenname: Dennis W surname: Dickson fullname: Dickson, Dennis W – sequence: 14 givenname: Ellen surname: Gelpi fullname: Gelpi, Ellen – sequence: 15 givenname: Florian surname: Krismer fullname: Krismer, Florian – sequence: 16 givenname: Gerard D surname: Schellenberg fullname: Schellenberg, Gerard D – sequence: 17 givenname: Gesine surname: Respondek fullname: Respondek, Gesine – sequence: 18 givenname: Gil surname: Rabinovici fullname: Rabinovici, Gil – sequence: 19 givenname: Gregor K surname: Wenning fullname: Wenning, Gregor K – sequence: 20 givenname: Günter U surname: Höglinger fullname: Höglinger, Günter U – sequence: 21 givenname: Huw R surname: Morris fullname: Morris, Huw R – sequence: 22 givenname: Irene surname: Litvan fullname: Litvan, Irene – sequence: 23 givenname: James B surname: Rowe fullname: Rowe, James B – sequence: 24 givenname: Jan surname: Kassubek fullname: Kassubek, Jan – sequence: 25 givenname: Jean-Christophe surname: Corvol fullname: Corvol, Jean-Christophe – sequence: 26 givenname: Jennifer L surname: Whitwell fullname: Whitwell, Jennifer L – sequence: 27 givenname: Johannes surname: Levin fullname: Levin, Johannes – sequence: 28 givenname: John surname: van Swieten fullname: van Swieten, John – sequence: 29 givenname: Kailash P surname: Bhatia fullname: Bhatia, Kailash P – sequence: 30 givenname: Keith A surname: Josephs fullname: Josephs, Keith A – sequence: 31 givenname: Klaus surname: Seppi fullname: Seppi, Klaus – sequence: 32 givenname: Lawrence I surname: Golbe fullname: Golbe, Lawrence I – sequence: 33 givenname: Maria surname: Stamelou fullname: Stamelou, Maria – sequence: 34 givenname: Murray surname: Grossman fullname: Grossman, Murray – sequence: 35 givenname: Peter surname: Nestor fullname: Nestor, Peter – sequence: 36 givenname: Richard surname: Dodel fullname: Dodel, Richard – sequence: 37 givenname: Stefan surname: Lorenzl fullname: Lorenzl, Stefan – sequence: 38 givenname: Thilo surname: van Eimeren fullname: van Eimeren, Thilo – sequence: 39 givenname: Thomas surname: Arzberger fullname: Arzberger, Thomas – sequence: 40 givenname: Ulrich surname: Müller fullname: Müller, Ulrich – sequence: 41 givenname: Wassilios G surname: Meissner fullname: Meissner, Wassilios G – sequence: 42 givenname: Werner surname: Poewe fullname: Poewe, Werner – sequence: 43 givenname: Wolfgang H surname: Oertel fullname: Oertel, Wolfgang H – sequence: 44 givenname: Yaroslau surname: Compta fullname: Compta, Yaroslau – sequence: 45 givenname: Yvette surname: Bordelon fullname: Bordelon, Yvette |
| Copyright | 2017 International Parkinson and Movement Disorder Society 2017 International Parkinson and Movement Disorder Society. Distributed under a Creative Commons Attribution 4.0 International License |
| Copyright_xml | – notice: 2017 International Parkinson and Movement Disorder Society – notice: 2017 International Parkinson and Movement Disorder Society. – notice: Distributed under a Creative Commons Attribution 4.0 International License |
| CorporateAuthor | for the Movement Disorder Society–endorsed PSP Study Group Movement Disorder Society-endorsed PSP Study Group Tumor microenvironment Institutionen för kliniska vetenskaper, Lund MultiPark: Multidisciplinary research focused on Parkinson's disease Lunds universitet Profile areas and other strong research environments Department of Clinical Sciences, Malmö Lund University Tumörmikromiljö Department of Clinical Sciences, Lund Section I Strategiska forskningsområden (SFO) Faculty of Medicine Strategic research areas (SRA) Clinical Memory Research Klinisk minnesforskning Sektion I Medicinska fakulteten Profilområden och andra starka forskningsmiljöer Institutionen för kliniska vetenskaper, Malmö |
| CorporateAuthor_xml | – name: for the Movement Disorder Society–endorsed PSP Study Group – name: Movement Disorder Society-endorsed PSP Study Group – name: Faculty of Medicine – name: Medicinska fakulteten – name: Strategiska forskningsområden (SFO) – name: Institutionen för kliniska vetenskaper, Malmö – name: Institutionen för kliniska vetenskaper, Lund – name: Clinical Memory Research – name: Section I – name: Strategic research areas (SRA) – name: Lunds universitet – name: Sektion I – name: Department of Clinical Sciences, Lund – name: Klinisk minnesforskning – name: Tumörmikromiljö – name: Profilområden och andra starka forskningsmiljöer – name: Lund University – name: Profile areas and other strong research environments – name: Tumor microenvironment – name: MultiPark: Multidisciplinary research focused on Parkinson's disease – name: Department of Clinical Sciences, Malmö |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 1XC 5PM ADTPV AOWAS D95 |
| DOI | 10.1002/mds.26987 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Hyper Article en Ligne (HAL) PubMed Central (Full Participant titles) SwePub SwePub Articles SWEPUB Lunds universitet |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1531-8257 |
| EndPage | 864 |
| ExternalDocumentID | oai_portal_research_lu_se_publications_3695e927_88b5_425b_8028_8f2527a8d8b2 PMC5516529 oai:HAL:hal-04591972v1 28467028 10_1002_mds_26987 MDS26987 |
| Genre | article Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: Bischof Dr. Karl Golser Stiftung – fundername: Tau Consortium – fundername: the International Parkinson and Movement Disorder Society – fundername: UK PSP Association – fundername: Alzheimer's Society and Alzheimer's Research UK – fundername: NIH funderid: R01‐NS89757; R01‐DC12519; P01‐AG017586; P50‐NS053488; P30‐AG010124 – fundername: MRC – fundername: Deutsche Forschungsgemeinschaft (DFG) funderid: HO 2402/11‐1 – fundername: German Center for Neurodegenerative Diseases e.V. (DZNE) – fundername: PSP Association and CBD‐Solutions – fundername: NINDS NIH HHS grantid: K23 NS088341 – fundername: Wellcome Trust – fundername: Medical Research Council grantid: MC_U105597119 – fundername: NIA NIH HHS grantid: P30 AG010124 – fundername: Medical Research Council grantid: MR/L016397/1 – fundername: Medical Research Council grantid: G0700943 – fundername: Wellcome Trust grantid: 103838 – fundername: NINDS NIH HHS grantid: R01 NS089757 – fundername: NIDCD NIH HHS grantid: R01 DC012519 – fundername: NINDS NIH HHS grantid: U54 NS092089 |
| GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 123 1CY 1L6 1OB 1OC 1ZS 31~ 33P 3PY 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC FYBCS G-S G.N GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M6M MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWD RWI RX1 RYL SAMSI SUPJJ SV3 TEORI TWZ UB1 V2E V9Y W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WXI WXSBR XG1 XV2 YCJ ZGI ZZTAW ~IA ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY AIQQE CITATION O8X CGR CUY CVF ECM EIF NPM 7X8 1XC 5PM ADTPV AOWAS D95 |
| ID | FETCH-LOGICAL-c5397-269dbd68e4bd9804e34bab9407b65d01277e4f75392d5101d0b6a47b18cf2aaa3 |
| IEDL.DBID | DRFUL |
| ISICitedReferencesCount | 1740 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000402969400010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0885-3185 1531-8257 |
| IngestDate | Thu Nov 27 03:11:38 EST 2025 Tue Nov 04 01:32:12 EST 2025 Tue Oct 14 20:48:54 EDT 2025 Fri Jul 11 12:04:29 EDT 2025 Mon Jul 21 05:50:17 EDT 2025 Tue Nov 18 22:30:51 EST 2025 Sat Nov 29 07:08:10 EST 2025 Wed Jan 22 16:53:05 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | clinical diagnostic criteria consensus-based evidence-based progressive supranuclear palsy |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2017 International Parkinson and Movement Disorder Society. Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5397-269dbd68e4bd9804e34bab9407b65d01277e4f75392d5101d0b6a47b18cf2aaa3 |
| Notes | Full financial disclosures and author roles may be found in the online version of this article. Nothing to report. Relevant conflicts of interest/financial disclosures Funding agencies The project was supported by the Bischof Dr. Karl Golser Stiftung, CurePSP, Deutsche Forschungsgemeinschaft (DFG, HO 2402/11‐1), German Center for Neurodegenerative Diseases e.V. (DZNE), German PSP Gesellschaft, Tau Consortium, UK PSP Association, and the International Parkinson and Movement Disorder Society. Drs. Höglinger, Respondek, Stamelou, Golbe, Boxer, and Litvan made an equal contribution. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 PMCID: PMC5516529 Drs. Hoglinger, Respondek, Stamelou, Golbe, Boxer, and Litvan made an equal contribution. |
| ORCID | 0000-0003-2172-7527 0000-0001-7587-6187 0000-0003-1668-9925 0000-0001-8185-286X 0000-0001-7325-0199 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/5516529 |
| PMID | 28467028 |
| PQID | 1894922355 |
| PQPubID | 23479 |
| PageCount | 16 |
| ParticipantIDs | swepub_primary_oai_portal_research_lu_se_publications_3695e927_88b5_425b_8028_8f2527a8d8b2 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5516529 hal_primary_oai_HAL_hal_04591972v1 proquest_miscellaneous_1894922355 pubmed_primary_28467028 crossref_citationtrail_10_1002_mds_26987 crossref_primary_10_1002_mds_26987 wiley_primary_10_1002_mds_26987_MDS26987 |
| PublicationCentury | 2000 |
| PublicationDate | June 2017 |
| PublicationDateYYYYMMDD | 2017-06-01 |
| PublicationDate_xml | – month: 06 year: 2017 text: June 2017 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Movement disorders |
| PublicationTitleAlternate | Mov Disord |
| PublicationYear | 2017 |
| Publisher | Wiley |
| Publisher_xml | – name: Wiley |
| References | 2002; 17 2009; 24 2015; 6 2013; 28 2012; 124 2017; 81 2008; 14 2011; 31 2016; 31 2008 1994; 44 2005; 20 2013; 70 2012; 18 1999; 246 2003; 18 2014; 29 2017; pii 2012; 323 2014; 40 1996; 55 2016; 4 2013; 19 2010; 25 2003; 105 2013; 33 2004; 19 2006; 65 2006; 66 1997; 120 2015; 41 2011; 70 2005; 128 1964; 10 1996; 60 2010; 133 2003; 49 2011; 43 1999; 53 2008; 21 1996; 47 2007; 22 2006; 129 2010; 30 2007; 69 2010; 6 e_1_2_8_28_1 e_1_2_8_24_1 e_1_2_8_47_1 Whitwell JL (e_1_2_8_40_1) e_1_2_8_26_1 e_1_2_8_49_1 e_1_2_8_3_1 e_1_2_8_5_1 Boxer AL (e_1_2_8_44_1) e_1_2_8_7_1 e_1_2_8_9_1 e_1_2_8_20_1 e_1_2_8_43_1 e_1_2_8_22_1 e_1_2_8_45_1 e_1_2_8_41_1 e_1_2_8_17_1 Respondek G (e_1_2_8_39_1) e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_36_1 e_1_2_8_15_1 e_1_2_8_32_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_51_1 e_1_2_8_30_1 e_1_2_8_29_1 e_1_2_8_25_1 e_1_2_8_46_1 e_1_2_8_27_1 e_1_2_8_48_1 e_1_2_8_2_1 e_1_2_8_4_1 e_1_2_8_6_1 e_1_2_8_8_1 e_1_2_8_21_1 Scottish Intercollegiate Guidelines Network (e_1_2_8_38_1) 2008 e_1_2_8_42_1 e_1_2_8_23_1 e_1_2_8_18_1 e_1_2_8_14_1 e_1_2_8_35_1 e_1_2_8_16_1 e_1_2_8_37_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_50_1 |
| References_xml | – volume: 29 start-page: 1758 year: 2014 end-page: 1766 article-title: The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases publication-title: Mov Disord – volume: 4 start-page: 120 year: 2016 article-title: An autopsy‐confirmed case of progressive supranuclear palsy with predominant postural instability publication-title: Acta Neuropathol Commun – volume: 30 start-page: 24 year: 2010 end-page: 35 article-title: Clinical heterogeneity in progressive supranuclear palsy: problems of clinical diagnostic criteria of NINDS‐SPSP in a retrospective study of seven Japanese autopsy cases publication-title: Neuropathology – volume: 14 start-page: 517 year: 2008 end-page: 519 article-title: Pure akinesia as initial presentation of PSP: a clinicopathological study publication-title: Parkinsonism Relat Disord – volume: 124 start-page: 23 year: 2012 end-page: 35 article-title: CSF biomarkers cutoffs: the importance of coincident neuropathological diseases publication-title: Acta Neuropathol – volume: 120 start-page: 65 year: 1997 end-page: 74 article-title: Which clinical features differentiate progressive supranuclear palsy (Steele‐Richardson‐Olszewski syndrome) from related disorders?. A clinicopathological study publication-title: Brain – volume: 129 start-page: 1385 year: 2006 end-page: 1398 article-title: Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech publication-title: Brain – volume: 25 start-page: 357 year: 2010 end-page: 362 article-title: What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy‐parkinsonism (PSP‐P)? publication-title: Mov Disord – volume: 22 start-page: 1954 year: 2007 end-page: 1958 article-title: Long lasting pure freezing of gait preceding progressive supranuclear palsy: a clinicopathological study publication-title: Mov Disord – volume: 65 start-page: 396 year: 2006 end-page: 405 article-title: Atypical progressive supranuclear palsy with corticospinal tract degeneration publication-title: J Neuropathol Exp Neurol – volume: 6 start-page: 148 year: 2010 end-page: 151 article-title: Behavioral changes as the earliest clinical manifestation of progressive supranuclear palsy publication-title: J Clin Neurol – volume: 19 start-page: 181 year: 2004 end-page: 189 article-title: Accuracy of clinical diagnosis of progressive supranuclear palsy publication-title: Mov Disord – volume: 55 start-page: 97 year: 1996 end-page: 105 article-title: Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders publication-title: J Neuropathol Exp Neurol – volume: 41 start-page: 3 year: 2015 end-page: 23 article-title: Neuropathology of tauopathies: principles and practice publication-title: Neuropathol Appl Neurobiol – volume: 22 start-page: 2235 year: 2007 end-page: 2241 article-title: Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy publication-title: Mov Disord – volume: 49 start-page: 72 year: 2003 end-page: 78 article-title: Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology publication-title: Eur Neurol – volume: 43 start-page: 699 year: 2011 end-page: 705 article-title: Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy publication-title: Nat Genet – volume: 53 start-page: 1292 year: 1999 end-page: 1299 article-title: Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias publication-title: Neurology – volume: 28 start-page: 504 year: 2013 end-page: 509 article-title: Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy publication-title: Mov Disord – volume: 20 start-page: 982 year: 2005 end-page: 988 article-title: Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome publication-title: Mov Disord – volume: 40 start-page: 149 year: 2014 end-page: 163 article-title: Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant publication-title: Neuropathol Appl Neurobiol – article-title: Targeting tau therapeutics to PSP: support from new diagnostic criteria and biomarkers publication-title: Lancet Neurol – volume: 133 start-page: 2045 year: 2010 end-page: 2057 article-title: Does corticobasal degeneration exist?. A clinicopathological re‐evaluation publication-title: Brain – volume: 128 start-page: 1247 year: 2005 end-page: 1258 article-title: Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP‐parkinsonism publication-title: Brain – year: 2008 – volume: 60 start-page: 615 year: 1996 end-page: 620 article-title: Natural history of progressive supranuclear palsy (Steele‐Richardson‐Olszewski syndrome) and clinical predictors of survival: a clinicopathological study publication-title: J Neurol Neurosurg Psychiatry – volume: 66 start-page: 41 year: 2006 end-page: 48 article-title: Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP publication-title: Neurology – volume: 24 start-page: 1312 year: 2009 end-page: 1318 article-title: Cerebellar involvement in progressive supranuclear palsy: a clinicopathological study publication-title: Mov Disord – volume: 19 start-page: 1149 year: 2013 end-page: 1151 article-title: Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia publication-title: Parkinsonism Relat Disord – article-title: Which ante‐mortem clinical features predict progressive supranuclear palsy pathology? publication-title: Mov Disord – volume: 69 start-page: 723 year: 2007 end-page: 729 article-title: Frontal presentation in progressive supranuclear palsy publication-title: Neurology – volume: 105 start-page: 610 year: 2003 end-page: 614 article-title: Progressive supranuclear palsy presenting with primary progressive aphasia—clinicopathological report of an autopsy case publication-title: Acta Neuropathol – volume: pii start-page: aww340 year: 2017 article-title: [18F]AV‐1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy publication-title: Brain – volume: 10 start-page: 333 year: 1964 end-page: 359 article-title: Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia publication-title: Arch Neurol – volume: 18 start-page: 478 year: 2012 end-page: 488 article-title: Autopsy‐proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia publication-title: Neurocase. – volume: 81 start-page: 117 year: 2017 end-page: 128 article-title: Pathologic correlations of [F‐18]‐AV‐1451 imaging in non‐Alzheimer tauopathies publication-title: Ann Neurol – volume: 47 start-page: 1 year: 1996 end-page: 9 article-title: Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele‐Richardson‐Olszewski syndrome): report of the NINDS‐SPSP international workshop publication-title: Neurology – volume: 70 start-page: 327 year: 2011 end-page: 340 article-title: Clinicopathological correlations in corticobasal degeneration publication-title: Ann Neurol – volume: 33 start-page: 561 year: 2013 end-page: 567 article-title: An autopsied case of progressive supranuclear palsy presenting with cerebellar ataxia and severe cerebellar involvement publication-title: Neuropathology – article-title: Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be? publication-title: Mov Disord – volume: 31 start-page: 653 year: 2016 end-page: 662 article-title: Cerebellar ataxia in progressive supranuclear palsy: an autopsy study of PSP‐C publication-title: Mov Disord – volume: 6 start-page: 7247 year: 2015 article-title: Genome‐wide association study identifies microtubule‐associated protein tau (MAPT) and myelin‐associated oligodendrocytic basic protein (MOBP) as shared genetic risk factors for corticobasal degeneration and progressive supranuclear palsy publication-title: Nat Commun – volume: 44 start-page: 2015 year: 1994 end-page: 2019 article-title: Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy) publication-title: Neurology – volume: 31 start-page: 4379 year: 2011 end-page: 4387 article-title: Distinctive features of saccadic intrusions and microsaccades in progressive supranuclear palsy publication-title: J Neurosci – volume: 21 start-page: 688 year: 2008 end-page: 692 article-title: Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy publication-title: Curr Opin Neurol – volume: 17 start-page: 1255 year: 2002 end-page: 1264 article-title: Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases publication-title: Mov Disord – volume: 70 start-page: 1411 year: 2013 end-page: 1417 article-title: Development and validation of pedigree classification criteria for frontotemporal lobar degeneration publication-title: JAMA Neurol – volume: 323 start-page: 147 year: 2012 end-page: 153 article-title: Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia publication-title: J Neurol Sci – volume: 18 start-page: 467 year: 2003 end-page: 486 article-title: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders publication-title: Mov Disord – volume: 246 start-page: II6 issue: Suppl 2 year: 1999 end-page: II15 article-title: Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration publication-title: J Neurol – ident: e_1_2_8_29_1 doi: 10.1016/j.jns.2012.09.005 – ident: e_1_2_8_14_1 doi: 10.1002/mds.25327 – ident: e_1_2_8_36_1 doi: 10.1093/brain/awl078 – ident: e_1_2_8_3_1 doi: 10.1097/00005072-199601000-00010 – ident: e_1_2_8_34_1 doi: 10.1159/000068502 – ident: e_1_2_8_21_1 doi: 10.1002/mds.21612 – ident: e_1_2_8_40_1 article-title: Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be? publication-title: Mov Disord – ident: e_1_2_8_30_1 doi: 10.1002/mds.22583 – ident: e_1_2_8_41_1 doi: 10.1212/WNL.44.11.2015 – ident: e_1_2_8_16_1 doi: 10.1186/s40478-016-0391-7 – ident: e_1_2_8_17_1 doi: 10.1002/mds.22977 – ident: e_1_2_8_33_1 doi: 10.1002/mds.26499 – ident: e_1_2_8_19_1 doi: 10.3988/jcn.2010.6.3.148 – ident: e_1_2_8_2_1 doi: 10.1001/archneur.1964.00460160003001 – ident: e_1_2_8_25_1 doi: 10.1212/01.wnl.0000191307.69661.c3 – ident: e_1_2_8_32_1 doi: 10.1016/j.parkreldis.2013.07.019 – ident: e_1_2_8_48_1 doi: 10.1002/ana.24844 – ident: e_1_2_8_37_1 doi: 10.1097/WCO.0b013e3283168ddd – ident: e_1_2_8_4_1 doi: 10.1007/BF03161076 – ident: e_1_2_8_7_1 doi: 10.1093/brain/120.1.65 – ident: e_1_2_8_6_1 doi: 10.1212/WNL.47.1.1 – ident: e_1_2_8_51_1 doi: 10.1523/JNEUROSCI.2600-10.2011 – ident: e_1_2_8_15_1 doi: 10.1136/jnnp.60.6.615 – ident: e_1_2_8_28_1 doi: 10.1097/01.jnen.0000218446.38158.61 – ident: e_1_2_8_22_1 doi: 10.1016/j.parkreldis.2007.11.004 – ident: e_1_2_8_8_1 doi: 10.1212/WNL.53.6.1292 – ident: e_1_2_8_27_1 doi: 10.1093/brain/awq123 – ident: e_1_2_8_23_1 doi: 10.1002/mds.21698 – ident: e_1_2_8_42_1 doi: 10.1038/ng.859 – ident: e_1_2_8_31_1 doi: 10.1111/neup.12012 – ident: e_1_2_8_18_1 doi: 10.1212/01.wnl.0000267643.24870.26 – ident: e_1_2_8_9_1 doi: 10.1002/mds.10680 – ident: e_1_2_8_44_1 article-title: Targeting tau therapeutics to PSP: support from new diagnostic criteria and biomarkers publication-title: Lancet Neurol – volume-title: SIGN 50. A Guideline Developer's Handbook year: 2008 ident: e_1_2_8_38_1 – ident: e_1_2_8_49_1 doi: 10.1093/brain/aww340 – ident: e_1_2_8_5_1 doi: 10.1111/nan.12208 – ident: e_1_2_8_43_1 doi: 10.1002/mds.10459 – ident: e_1_2_8_46_1 doi: 10.1002/ana.22424 – ident: e_1_2_8_47_1 doi: 10.1007/s00401-012-0983-7 – ident: e_1_2_8_24_1 doi: 10.1002/mds.20478 – ident: e_1_2_8_39_1 article-title: Which ante‐mortem clinical features predict progressive supranuclear palsy pathology? publication-title: Mov Disord – ident: e_1_2_8_50_1 doi: 10.1001/jamaneurol.2013.3956 – ident: e_1_2_8_20_1 doi: 10.1080/13554794.2011.627345 – ident: e_1_2_8_12_1 doi: 10.1002/mds.10211 – ident: e_1_2_8_11_1 doi: 10.1002/mds.26054 – ident: e_1_2_8_13_1 doi: 10.1111/j.1440-1789.2009.01032.x – ident: e_1_2_8_26_1 doi: 10.1111/nan.12037 – ident: e_1_2_8_35_1 doi: 10.1007/s00401-003-0682-5 – ident: e_1_2_8_10_1 doi: 10.1093/brain/awh488 – ident: e_1_2_8_45_1 doi: 10.1038/ncomms8247 |
| SSID | ssj0011516 |
| Score | 2.7001956 |
| Snippet | ABSTRACT
Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, published in 1996 by the National Institute of... Background : PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, published in 1996 by the National Institute of Neurological... PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, published in 1996 by the National Institute of Neurological Disorders and... Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria, published in 1996 by the National Institute of Neurological... |
| SourceID | swepub pubmedcentral hal proquest pubmed crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 853 |
| SubjectTerms | clinical diagnostic criteria Clinical Medicine consensus‐based evidence‐based Human health and pathology Humans Klinisk medicin Life Sciences Medical and Health Sciences Medicin och hälsovetenskap Neurologi Neurology Practice Guidelines as Topic - standards progressive supranuclear palsy Societies, Medical - standards Supranuclear Palsy, Progressive - diagnosis Supranuclear Palsy, Progressive - physiopathology |
| Title | Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmds.26987 https://www.ncbi.nlm.nih.gov/pubmed/28467028 https://www.proquest.com/docview/1894922355 https://hal.science/hal-04591972 https://pubmed.ncbi.nlm.nih.gov/PMC5516529 |
| Volume | 32 |
| WOSCitedRecordID | wos000402969400010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1531-8257 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0011516 issn: 1531-8257 databaseCode: DRFUL dateStart: 19990101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFD5aO4R4GXcIl8kgHngJS504tuFpYlR72CYETKoQkmXHjlqpS6umrbR_z7GTBqKBhMRbFDuJY5_LZ5_jzwBvclaUwqQ6NpkTcaYtj3Va8DiRNNdGYhktwmET_OJCTCby8x582O2FafghugU3rxnBXnsF16Y--kUaemXrdzTHKfMA9inKLRvC_smX8eVZF0RAZ5Y3IJKFTcI7YqGEHnUP99zRYOqTIW8izZsJky2taB_RBpc0vvtfP3MPDlokSo4b0bkPe656ALfP21j7Q_jRUobOiW3S8WY1WZQkJHT53NmtI_Vmia7OMyLrFVmiIF-_Jyh35GoRWMjXxLbcnqRukkMJ2ihPDq0fweX407ePp3F7FkNcMIQsMTbOGpsLlxkrRZK5NDM4ljgdNDmzPn7NXVbi3EdS69XcJibXGTcjUZRUa50-hmG1qNxTIOWIapEzZx3iA825QUyJloAmWSEzltAI3u6GRBUtUbk_L2OuGoplqrC3VOitCF53VZcNO8cfK-G4duWeT_v0-Ez5e4hnpT93bTuK4NVu2BUqmI-a6MotNrUaCZlJBFGMRfCkEYPuXdSjN0RoEfCegPQ-1i-pZtNA4u0DlIzKCL43otR_JEy9VMv3NFXzjaqdWv62kKvSXDInKVdCGKbQ8holsCVKlJRRroVFLcOeDEL3975R5ydfw8Wzf6_6HO5Qj23CUtQLGK5XG_cSbhXb9axeHcKAT8Rhq4o_AcD1OKQ |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bi9QwFD7sRdQX75d6jeKDL3U7maRNxJfFdRhxZhDdhUWEkDQpMzDbGaYzA_57T9JOtayC4Ftp0jZNvpN8yTn5AvAq5XkhTF_HhjkRM22zWPfzLE4kTbWRmEbzcNhENpmI83P5eQ_e7fbC1PoQ7YKbt4zQX3sD9wvSR79UQy9s9YamOGfeh0OGMEJ8H558GZyNWi8CjmZpzSJ52CW8UxZK6FH7cGc82p_6aMjLVPNyxGSjK9qltGFMGtz8v7-5BTcaLkqOa_Dchj1X3oGr48bbfhe-N6Khc2LrgLxZRRYFCSFdPnp260i1WeJg5zWR9YosEco_3hJEHrlYBB3yNbGNuiep6vBQgr2Ul4fW9-Bs8OH0_TBuTmOIc46kJcbCWWNT4ZixUiTM9ZnB1sQJoUm59R7szLECZz-SWm_oNjGpZpnpibygWuv-fTgoF6V7CKToUS1S7qxDhqCzzCCrxL6AJiyXjCc0gte7NlF5I1XuT8yYq1pkmSqsLRVqK4KXbdZlrc_xx0zYsG26V9QeHo-Uv4eMVvqT17a9CF7s2l2hiXm_iS7dYlOpnpBMIo3iPIIHNQ7ad1HP35CjRZB1ENL5WDelnE2DjLd3UXIqI_hWY6n7SJh8qUbxaarmG1U5tfxtKVf1U8mdpJkSwnCFfa9RAkuiREE5zbSwaGdYkwF1f68bNT75Gi4e_XvW53BteDoeqdHHyafHcJ16phMWpp7AwXq1cU_hSr5dz6rVs8YifwL8wzus |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9swED_adJS97PvD-9TGHvbi1VEkWxp7KctCx9JQthXKGAjJkkkgTUycBPbf7yQ73kw3GOzNWLItS3fS73Sn3wG8SnleCDPQsWFOxEzbLNaDPIsTSVNtJJbRPCSbyCYTcXEhz_bg3e4sTM0P0W64ec0I87VXcFfa4ugXa-ilrd7QFG3mfThgPolMDw6Gn0fn49aLgKtZWqNIHk4J75iFEnrUPtxZj_anPhryKtS8GjHZ8Ip2IW1Yk0Y3_-9vbsGNBouS41p4bsOeW9yBw9PG234XvjekoXNi64C8WUWWBQkhXT56dutItSlxsfOcyHpFShTlH28JSh65XAYe8jWxDbsnqerwUIKzlKeH1vfgfPTh6_uTuMnGEOccQUuMjbPGpsIxY6VImBswg6OJBqFJufUe7MyxAq0fSa1XdJuYVLPM9EVeUK314D70FsuFewik6FMtUu6sQ4Sgs8wgqsS5gCYsl4wnNILXuzFReUNV7jNmzFVNskwV9pYKvRXBy7ZqWfNz_LESDmxb7hm1T47Hyt9DRCt95rVtP4IXu3FXqGLeb6IXbrmpVF9IJhFGcR7Bg1oO2ndRj98Qo0WQdSSk87FuyWI2DTTe3kXJqYzgWy1L3UeC8aUaxqepmm9U5VT521auGqSSO0kzJYThCudeowS2RImCcpppYVHPsCeD1P29b9Tp8Eu4ePTvVZ_D4dlwpMYfJ58ew3XqgU7Yl3oCvfVq457CtXy7nlWrZ41C_gQzsjsn |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+diagnosis+of+progressive+supranuclear+palsy%3A+The+movement+disorder+society+criteria&rft.jtitle=Movement+disorders&rft.au=H%C3%B6glinger%2C+G%C3%BCnter&rft.au=Respondek%2C+Gesine&rft.au=Stamelou%2C+Maria&rft.au=Kurz%2C+Carolin&rft.date=2017-06-01&rft.pub=Wiley&rft.issn=0885-3185&rft.eissn=1531-8257&rft.volume=32&rft.issue=6&rft.spage=853&rft.epage=864&rft_id=info:doi/10.1002%2Fmds.26987&rft_id=info%3Apmid%2F28467028&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=oai%3AHAL%3Ahal-04591972v1 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0885-3185&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0885-3185&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0885-3185&client=summon |